<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Pharmacology-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 30513,
    "choices": [
      {
        "id": 121930,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic gout</span></span></span></p>"
      },
      {
        "id": 121931,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Paralytic ileus</span></span></span></p>"
      },
      {
        "id": 121932,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psoriatic arthritis</span></span></span></p>"
      },
      {
        "id": 121933,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rheumatoid arthritis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Pegloticase is used in the treatment of&nbsp;</span></span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q8784388",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306183,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. Chronic gout</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pegloticase is a recombinant form of uricase, an enzyme that converts uric acid into allantoin, a more water-soluble substance that is easily excreted by the kidneys. Humans naturally lack this enzyme, and pegloticase is specifically designed to address the accumulation of uric acid in patients with gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pegloticase is particularly indicated for the treatment of chronic gout in patients who have not responded to conventional therapies. Due to its potential immunogenicity, which can lead to infusion reactions including anaphylaxis, pegloticase is reserved for rare cases of refractory symptomatic chronic gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Paralytic ileus:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus is a condition of impaired bowel motility. Pegloticase has no role in the treatment of paralytic ileus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Psoriatic arthritis:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. Treatments typically include NSAIDs, DMARDs, and biologics, but not pegloticase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Rheumatoid arthritis:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid arthritis is an autoimmune disorder treated with NSAIDs, corticosteroids, DMARDs, and biologic agents. Pegloticase is not used in the management of rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pegloticase is used in the treatment of chronic gout, particularly in patients who have not responded to other therapies, due to its ability to lower uric acid levels by converting it to allantoin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 235</span></span></strong></span></span></p>",
    "correct_choice_id": 121930,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30514,
    "choices": [
      {
        "id": 121934,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic M2 receptor</span></span></span></p>"
      },
      {
        "id": 121935,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dopamine D2 receptor</span></span></span></p>"
      },
      {
        "id": 121936,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serotonin 5 HT 1 receptor</span></span></span></p>"
      },
      {
        "id": 121937,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Angiotensin 1 receptor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">G-protein</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"> coupled receptor that does not act through opening of potassium channels is</span></span></span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q4335409",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306184,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. D. Angiotensin 1 receptor&nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">G-protein coupled receptors (GPCRs) can have various mechanisms of action, including the opening of potassium channels or increasing intracellular calcium levels. Opening potassium channels typically results in hyperpolarization and inhibition, whereas increasing calcium levels generally leads to excitation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Muscarinic M2 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor is coupled to G-proteins that open potassium channels, leading to hyperpolarization and inhibition, particularly in cardiac tissue where it slows the heart rate.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dopamine D2 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor is also coupled to G-proteins that open potassium channels, resulting in hyperpolarization and inhibition. It is involved in regulating neurotransmitter release and motor control.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Serotonin 5 HT 1 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor acts similarly by opening potassium channels, leading to hyperpolarization and inhibition. It plays a role in mood regulation and other central nervous system functions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Angiotensin 1 receptor</span></strong><span style=\"font-size:12.0pt\">: Unlike the others, the Angiotensin 1 receptor does not act through the opening of potassium channels. Instead, it is coupled to G-proteins that activate the phospholipase C pathway, leading to an increase in intracellular calcium levels. This results in vasoconstriction and increased blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Muscarinic M2 receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This receptor opens potassium channels, leading to hyperpolarization and inhibition, particularly in the heart, where it decreases heart rate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dopamine D2 receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This receptor also opens potassium channels, resulting in hyperpolarization and inhibition, affecting neurotransmitter release and motor control.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serotonin 5 HT 1 receptor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This receptor acts through the opening of potassium channels, leading to hyperpolarization and inhibition, influencing mood and other central nervous system activities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">GPCR that acts through opening of K<sup>+</sup> channels can result in hyper-polarization, thus leading to inhibition. So, receptor which causes stimulation cannot act through opening of K<sup>+</sup> channels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Muscarinic M2 receptor, Dopamine D2 receptor and serotonin 5HT1 receptor act through opening of K<sup>+</sup> channels.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Whereas Angiotensin 1 receptor act by increasing Ca<sup>2+</sup>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: <strong>KDT 8<sup>th</sup>/56</strong></span></span></strong></span></span></p>",
    "correct_choice_id": 121937,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30517,
    "choices": [
      {
        "id": 121946,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zidovudine is used as monotherapy for post-exposure prophylaxis</span></span></span></p>"
      },
      {
        "id": 121947,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Washing hands with soap and water is advised</span></span></span></p>"
      },
      {
        "id": 121948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Baseline viral markers of health care personnel should be done at the time of prick</span></span></span></p>"
      },
      {
        "id": 121949,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Follow up viral markers of health care personnel should be measured at 6 weeks</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A nurse&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">got accidental prick from the HIV infected needle. Which of the following statements is false regarding the management of this nurse?&nbsp;</span></span></span></span>(AIIMS NOV 2019)</p>",
    "unique_key": "Q8884360",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306185,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. Zidovudine is used as monotherapy for post-exposure prophylaxis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Post-Exposure Prophylaxis (PEP)</span></strong><span style=\"font-size:12.0pt\"> involves a series of steps to reduce the risk of HIV infection after potential exposure, such as a needlestick injury.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Washing the Wound</span></strong><span style=\"font-size:12.0pt\">: Immediately after exposure, the wound should be washed thoroughly with soap and water. This helps to reduce the risk of infection.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Baseline Viral Markers</span></strong><span style=\"font-size:12.0pt\">: Blood samples should be taken from the exposed individual to measure baseline viral markers. This provides a reference point to determine if the infection was acquired.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Triple Drug Therapy</span></strong><span style=\"font-size:12.0pt\">: PEP should be initiated within 72 hours of exposure, preferably as soon as possible. The recommended regimen includes a combination of three antiretroviral drugs:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tenofovir</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lamivudine (or Emtricitabine)</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A boosted protease inhibitor (such as lopinavir/ritonavir)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zidovudine monotherapy is not recommended. Combination therapy is more effective in preventing seroconversion.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<ol start=\"4\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Follow-Up Testing</span></strong><span style=\"font-size:12.0pt\">: Follow-up viral markers should be measured at 6 weeks post-exposure to check for HIV infection. Additional testing may also be done at 3 months and 6 months.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Washing hands with soap and water is advised:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is correct. Washing the wound with soap and water immediately after exposure is a crucial first step.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Baseline viral markers of health care personnel should be done at the time of prick:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is correct. Establishing baseline viral markers at the time of exposure is essential for monitoring potential seroconversion.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Follow up viral markers of health care personnel should be measured at 6 weeks:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is correct. Follow-up testing at 6 weeks is recommended to detect any early seroconversion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">POST EXPOSURE PROPHYLAXIS</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Treatment should be started within 72 hours of exposure, preferably as early as possible</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">At first the wound is washed with soap and water.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Secondly before initiating drug therapy blood samples are taken to measure the baseline viral markers</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Then, triple drug therapy is given which includes Tenofovir, Lamivudine and a boosted protease inhibitor for 28 days.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">After 6 weeks again viral markers are measured to check for the infection.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/872</span></span></strong></span></span></p>",
    "correct_choice_id": 121946,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30519,
    "choices": [
      {
        "id": 121954,
        "text": "<p>C, D and E</p>"
      },
      {
        "id": 121955,
        "text": "<p>A, B and C</p>"
      },
      {
        "id": 121956,
        "text": "<p>A, C and D</p>"
      },
      {
        "id": 121957,
        "text": "<p>B and D only</p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;\">Which of the following is True regarding drugs used for viral infections?</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"color:#333333;\">Treatment of HCV with ribavirin is considered better than sofosbuvir</span></li><li><span style=\"color:#333333;\">Ombitasvir is inhibitor of proteins synthesis</span></li><li><span style=\"color:#333333;\">Imiquimod is used for Condyloma acuminata</span></li><li><span style=\"color:#333333;\">Simprevir inhibits protease of hepatitis C</span></li><li><span style=\"color:#333333;\">Oseltamivir is used for swine flu</span></li></ol>",
    "unique_key": "Q6935082",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306186,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"color:#333333;\"><strong>Ans.&nbsp;A. C, D and E</strong></span></p><p>&nbsp;</p><p><strong>C. Imiquimod is used for Condyloma acuminata:&nbsp;</strong>This statement is true. Imiquimod is an immunomodulator used for the treatment of various viral warts, including condyloma acuminata (genital warts).</p><p>&nbsp;</p><p><strong>D. Simprevir inhibits protease of hepatitis C:&nbsp;</strong>This statement is true. Simprevir is a protease inhibitor used in the treatment of HCV, which works by inhibiting the NS3/4A protease enzyme necessary for viral replication.</p><p>&nbsp;</p><p><strong>E. Oseltamivir is used for swine flu:&nbsp;</strong>This statement is true. Oseltamivir is an antiviral medication effective against influenza A (including H5N1 and H1N1, commonly known as swine flu) and influenza B.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Treatment of HCV with ribavirin is considered better than sofosbuvir:&nbsp;</strong>This statement is false. Ribavirin, when used for the treatment of Hepatitis C Virus (HCV), must be combined with injectable interferons, which have significant adverse effects. Sofosbuvir, a newer oral drug that inhibits the NS5B RNA polymerase, is preferred over ribavirin due to its better efficacy and fewer side effects.</p><p>&nbsp;</p><p><strong>Option B. Ombitasvir is an inhibitor of protein synthesis:&nbsp;</strong>This statement is false. Ombitasvir is an NS5A inhibitor, meaning it acts by inhibiting viral RNA replication and assembly of the hepatitis C virus (HCV), not protein synthesis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Sofosbuvir is preferred over ribavirin for HCV treatment due to better efficacy, ombitasvir is an NS5A inhibitor, imiquimod is used for condyloma acuminata, simprevir inhibits HCV protease, and oseltamivir is used for swine flu.</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-100220.jpg\" alt=\"\" width=\"1000\" height=\"462\"></p><p>&nbsp;</p><p><strong>Reference: KDT 8th/. 853,856,858</strong></p>",
    "correct_choice_id": 121954,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30520,
    "choices": [
      {
        "id": 121958,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-B, 4-E</span></span></span></p>"
      },
      {
        "id": 121959,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-D, 2-A, 3-E, 4-B</span></span></span></p>"
      },
      {
        "id": 121960,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-D, 4-E</span></span></span></p>"
      },
      {
        "id": 121961,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-B, 4-D</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug with mechanism of action are given in two columns. Which of the following is the correct match?</span></span></span>(AIIMS NOV 2019)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-124051.png\" style=\"height:296px; width:1000px\" /></p>",
    "unique_key": "Q3157540",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306187,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. 1-C, 2-A, 3-B, 4-E</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct matches between the drugs and their mechanisms of action are as follows:</span></span></span></p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Omalizumab - Anti-IgE (1-C)</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Omalizumab is used in the treatment of bronchial asthma. It works by binding to IgE, which plays a key role in allergic reactions.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Itolizumab - Anti-CD 6 (2-A)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Itolizumab is a new drug used for psoriasis. It targets CD6, a molecule involved in T-cell activation.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Daclizumab - Anti-CD 25 (3-B)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Daclizumab acts as an IL-2 receptor antagonist by binding to CD25, which is part of the IL-2 receptor. It is used as an immunosuppressant.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Belimumab - Anti-B lymphocyte stimulator (BlyS) (4-E)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Belimumab is used for the treatment of systemic lupus erythematosus (SLE). It inhibits B-lymphocyte stimulator, which is involved in the survival of B cells.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-101044.jpg\" style=\"height:355px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>TH</sup>/251-52,943</span></span></strong></span></span></p>",
    "correct_choice_id": 121958,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30524,
    "choices": [
      {
        "id": 121974,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both A and R are correct and R is correct explanation of A</span></span></span></p>"
      },
      {
        "id": 121975,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both A and R are correct and R is not correct explanation of A</span></span></span></p>"
      },
      {
        "id": 121976,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A is true and R is false</span></span></span></p>"
      },
      {
        "id": 121977,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A is false and R is true</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Assertion:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;In a patient</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"> admitted in hospital for community acquired pneumonia, combination therapy of beta lactams and azithromycin is given.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reason:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;The combination covers gram positive organisms as well as anaerobes.</span></span></span></span></p>",
    "unique_key": "Q5479919",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306188,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. C</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">. <strong>A is true and R is false</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">In patients admitted in hospital for community acquired pneumonia, combination therapy of beta lactams and azithromycin is given. Beta lactams covers the gram positive and gram negative organisms whereas azithromycin covers the atypical mycobacteria like mycoplasma and chlamydia.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Alternative to this therapy is fluoroquinolones.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">If a patient is not admitted, then either beta lactams alone or macrolides is prescribed.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:6pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hospitalized patients with community-acquired pneumonia, combination therapy of beta-lactams and azithromycin is used to cover typical and atypical bacterial pathogens, not anaerobes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: Katzung 13<sup>th</sup>/878</span></span></strong></span></span></p>",
    "correct_choice_id": 121976,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30525,
    "choices": [
      {
        "id": 121978,
        "text": "<p><span style=\"font-size:12.0pt;\">Clindamycin</span></p>"
      },
      {
        "id": 121979,
        "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
      },
      {
        "id": 121980,
        "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
      },
      {
        "id": 121981,
        "text": "<p><span style=\"font-size:12.0pt;\">Rovamycin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12.0pt;\">Drug of choice for treatment of bacterial vaginosis in pregnancy is</span></p>",
    "unique_key": "Q4821685",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306189,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Metronidazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Metronidazole</strong> is the drug of choice for the treatment of bacterial vaginosis, including in pregnancy. Bacterial vaginosis is a common vaginal infection caused by an imbalance of the normal bacterial flora.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Effectiveness</strong>: Metronidazole is highly effective against the anaerobic bacteria that are commonly implicated in bacterial vaginosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Safety</strong>: It is considered safe for use during pregnancy, making it the preferred treatment option.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clindamycin:&nbsp;</strong>Clindamycin is an alternative treatment for bacterial vaginosis and can be used if metronidazole is contraindicated or not tolerated. However, it is not the first-line treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Erythromycin:&nbsp;</strong>Erythromycin is not commonly used for bacterial vaginosis. It is more commonly used for infections caused by gram-positive bacteria and atypical pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rovamycin:&nbsp;</strong>Rovamycin (spiramycin) is a macrolide antibiotic used primarily for the treatment of toxoplasmosis in pregnancy. It is not used for bacterial vaginosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metronidazole is the drug of choice for treating bacterial vaginosis in pregnancy due to its effectiveness against anaerobic bacteria and its safety profile during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Rovamycin i.e. spiramycin (which is a macrolide) is drug of choice for toxoplasmosis in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/894-896.</strong></span></p>",
    "correct_choice_id": 121979,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30526,
    "choices": [
      {
        "id": 121982,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true</span></span></span></p>"
      },
      {
        "id": 121983,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B and C only</span></span></span></p>"
      },
      {
        "id": 121984,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, C, and E only</span></span></span></p>"
      },
      {
        "id": 121985,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B, D and E</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Which of the following statements regarding foscarnet are True? </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is used for resistant CMV infections</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Renal toxicity is seen </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is activated by viral thymidine kinase </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Regular monitoring of serum electrolytes is required </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It can cause genital ulceration </span></span></span></span></li>\r\n</ol>",
    "unique_key": "Q2794687",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306190,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans.&nbsp;D. A, B, D and E</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Foscarnet</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an antiviral medication used primarily for the treatment of cytomegalovirus (CMV) and other herpesvirus infections, particularly when the viruses are resistant to other treatments like ganciclovir and acyclovir.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statements:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. It is used for resistant CMV infections</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is true. Foscarnet is effective against CMV, including strains that are resistant to ganciclovir.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Renal toxicity is seen</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is true. Renal toxicity is a significant adverse effect of foscarnet, which can lead to acute renal failure and other renal complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Regular monitoring of serum electrolytes is required</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is true. Due to its potential to cause electrolyte imbalances, particularly hypocalcemia, regular monitoring of serum electrolytes is necessary during foscarnet therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E. It can cause genital ulceration</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is true. Genital ulceration is one of the potential side effects of foscarnet.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. It is activated by viral thymidine kinase:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is false. Foscarnet does not require activation by viral thymidine kinase. Unlike acyclovir and ganciclovir, foscarnet directly inhibits viral DNA polymerase, RNA polymerase, and HIV reverse transcriptase without needing to be phosphorylated by viral enzymes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for herpes simplex virus and varicella zoster virus infection is acyclovir.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Drug of choice for cytomegalovirus is ganciclovir.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Both acyclovir and ganciclovir are pro-drugs and require activation by kinases.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">FOSCARNET</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is a simple straight chain phosphonate.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It does not require activation by kinases.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is active against H. simplex (including strains resistant to acyclovir), CMV (including ganciclovir-resistant ones) and other herpes group viruses.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Oral absorption is poor. Its t&frac12; is 4&ndash;8 hours, and it is not metabolized by liver.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Toxicity of foscarnet is high. It damages kidney and produces a renal diabetes like condition; acute&nbsp;<strong>renal failure</strong>&nbsp;can also occur. Anemia, phlebitis, tremors, convulsions,&nbsp;<strong>genital ulceration</strong>&nbsp;and other neurological as well as constitutional symptoms due to&nbsp;<strong>hypocalcemia</strong>&nbsp;are frequent.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is administered by i.v. infusion</span></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/852, 853</span></span></strong></span></span></p>",
    "correct_choice_id": 121985,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 30527,
    "choices": [
      {
        "id": 121986,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thalidomide</span></span></span></p>"
      },
      {
        "id": 121987,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colistin</span></span></span></p>"
      },
      {
        "id": 121988,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ketamine</span></span></span></p>"
      },
      {
        "id": 121989,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halothane</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">hich of the following is a schedule X-drug?</span></span></span></span></p>",
    "unique_key": "Q4183133",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306191,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. C. Ketamine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Schedule X is for the psychotropic drugs i.e. addictive drugs. &nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Among given options, drug that comes under schedule X is KETAMINE. </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used medically for anesthesia but is also known for its misuse as a recreational drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Thalidomide:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide is not classified as a Schedule X drug. It is used for specific medical conditions like multiple myeloma and complications of leprosy, but it is not a psychotropic substance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Colistin:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colistin is an antibiotic used for treating multi-drug-resistant bacterial infections. It is not classified as a Schedule X drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Halothane:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Halothane is an inhalational anesthetic agent. It is not a Schedule X drug as it does not have psychotropic properties.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">IMPORTANT DRUG SCHEDULES</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Schedule G:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;Deals with details of drugs to be labeled &#39;CAUTION-it is dangerous to take this medicine except under medical supervision&#39;.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Schedule H:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;Deals with drugs and medicine to be sold on prescription-only.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Schedule R:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;Deals with standards for contraceptives.</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Schedule X:</span></span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&nbsp;Deals with psychotropic drugs which require special license for manufacturing and sale.</span></span></span></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 121988,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6970,
    "choices": [
      {
        "id": 27848,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with penicillin because of narrow therapeutic index</span></span></span></p>"
      },
      {
        "id": 27849,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with gentamicin because of narrow therapeutic index</span></span></span></p>"
      },
      {
        "id": 27850,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDM is done with both because of dangerous side effects</span></span></span></p>"
      },
      {
        "id": 27851,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both drugs do not need monitoring</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is correct for a patient on high dose of penicillin and gentamicin? iNICET NOV 2020)</span></span></p>",
    "unique_key": "Q6922280",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306192,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. TDM is done with gentamicin because of narrow therapeutic index</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Drug Monitoring has to be done for drugs that have a narrow safety margin. Gentamicin is an aminoglycoside antibiotic that acts by inhibiting the protein synthesis at the 30S ribosomal subunit of the bacteria. It is nephrotoxic as well as ototoxic. It has a narrow therapeutic margin; therefore, it requires TDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>TDM is done with gentamicin because of narrow therapeutic index</strong>: Gentamicin is an aminoglycoside antibiotic, and these drugs are known for their narrow therapeutic index. TDM is important for gentamicin to ensure effective therapeutic levels are achieved without causing toxicity. Aminoglycosides can cause nephrotoxicity (kidney damage) and ototoxicity (hearing loss), so monitoring blood levels is crucial to avoid these adverse effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TDM is done with penicillin because of narrow therapeutic index</strong>: This is not typically the case. Penicillin, for the most part, does not have a narrow therapeutic index, and Therapeutic Drug Monitoring (TDM) is generally not required for penicillin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TDM is done with both because of dangerous side effects</strong>: While it&#39;s true that both drugs can have side effects, TDM is generally only recommended for gentamicin because of its narrow therapeutic window and potential for serious side effects. Penicillin does not typically require TDM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Both drugs do not need monitoring</strong>: This statement is incorrect because gentamicin does require monitoring due to its narrow therapeutic index and potential for toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic Drug Monitoring (TDM) is crucial for gentamicin due to its narrow therapeutic index and potential for nephrotoxicity and ototoxicity. Penicillin, on the other hand, generally does not require TDM because it does not have a narrow therapeutic index.</span></span></span></p>",
    "correct_choice_id": 27849,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6973,
    "choices": [
      {
        "id": 27860,
        "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
      },
      {
        "id": 27861,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffMethotrexate</span></p>"
      },
      {
        "id": 27862,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeff\ufeff\ufeff\ufeffVinblastine</span></p>"
      },
      {
        "id": 27863,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeff\ufeff\ufeff\ufeffVincristine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A boy presents with pallor and lymphadenopathy; the X-ray of his skull is given below. Which of the following drug is not used for the management of the suspected diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/picture4_YOReme1.jpg\" alt=\"\" width=\"300\" height=\"286\"></span></p>",
    "unique_key": "Q7215210",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306193,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Vincristine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The X-ray of the skull is showing circumscribed punched out lesions in the skull of a boy whose history reveals the presence of pallor and lymphadenopathy. This is suggestive of Langerhans Cell Histiocytosis.</span></li><li><span style=\"font-size:12pt;\">Langerhans cell histiocytosis (LCH) is a rare disease in which an excess of immature Langerhans cells (a type of white blood cell) accumulates in various parts of the body, leading to tissue damage and dysfunction.</span></li><li><span style=\"font-size:12pt;\">The treatment of LCH depends on the severity and extent of the disease, as well as the age and overall health of the patient. Some cases of LCH can go away on their own, while others require treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>The main treatment options for LCH include:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. Observation: In some cases, particularly in mild cases that only involve one or a few areas of the body, doctors may recommend monitoring the disease closely without any treatment. The goal is to watch for any changes or progression of the disease and intervene if necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">2. Chemotherapy: Chemotherapy drugs are used to kill the abnormal Langerhans cells and control the disease. Some commonly used chemotherapy drugs for LCH include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Vinblastine</strong>: Vinblastine is a chemotherapy drug that is often used as the first-line treatment for LCH, particularly in children. It works by disrupting the growth of abnormal Langerhans cells. Vincristine is not recommended for LCH.</span></li><li><span style=\"font-size:12pt;\"><strong>Methotrexate</strong>: Methotrexate is another chemotherapy drug that is commonly used to treat LCH. It works by interfering with the growth of abnormal cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Cladribine</strong>: Cladribine is a chemotherapy drug that is sometimes used in more severe cases of LCH that do not respond to other treatments. It works by killing abnormal white blood cells.</span></li><li><span style=\"font-size:12pt;\"><strong>Etoposide</strong>: Etoposide is a chemotherapy drug that is sometimes used in combination with other drugs to treat LCH. It works by interfering with the ability of abnormal cells to divide and grow.</span></li><li><span style=\"font-size:12pt;\"><strong>Cyclophosphamide</strong>: Cyclophosphamide is a chemotherapy drug that is sometimes used in combination with other drugs to treat LCH. It works by interfering with the growth and division of abnormal cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Steroids</strong>: Steroids are often used in conjunction with chemotherapy to help reduce inflammation and improve symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Immunotherapy</strong>: Immunotherapy is a newer treatment option that involves using drugs that stimulate the immune system to attack and kill the abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Surgery</strong>: In some cases, surgery may be needed to remove damaged or diseased tissue, particularly if it is causing significant problems or pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;A. Cyclophosphamide: Explanation</strong>: Cyclophosphamide is used in combination with other drugs to treat LCH by interfering with the growth and division of abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;B. Methotrexate: Explanation</strong>: Methotrexate is used to treat LCH by interfering with the growth of abnormal cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;C. Vinblastine: Explanation</strong>: Vinblastine is commonly used as the first-line treatment for LCH, particularly in children, by disrupting the growth of abnormal Langerhans cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options&nbsp;D. Vincristine: Explanation</strong>: Vincristine is not recommended for LCH. Other chemotherapy drugs like vinblastine are preferred for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Langerhans Cell Histiocytosis (LCH) is treated with various chemotherapy drugs, but vincristine is not typically used for this condition. Vinblastine, methotrexate, cyclophosphamide, and other drugs are preferred for the management of LCH.</span></p>",
    "correct_choice_id": 27863,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6975,
    "choices": [
      {
        "id": 27868,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Need for drug monitoring</span></span></span></p>"
      },
      {
        "id": 27869,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECG monitoring for arrhythmias</span></span></span></p>"
      },
      {
        "id": 27870,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suicidal risk</span></span></span></p>"
      },
      {
        "id": 27871,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sedation being the side effect</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was treated with imipramine for a major depressive episode in the hospital for 4 weeks. What is the main concern while considering his discharge from the hospital?(INICET NOV 2020)</span></span></p>",
    "unique_key": "Q9594141",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306194,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp; Suicidal risk</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The main concern while considering the discharge of a patient who has been treated with imipramine for a major depressive episode is <strong>Suicidal Risk. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suicidal risk is a critical concern when discharging patients who have been treated for major depression. The risk of suicide can actually increase as the patient begins to recover, partly because they may gain more energy and motivation before their mood improves significantly. Further TCA are lethal in overdose. Therefore, ensuring that the patient has a safe environment, a follow-up plan, and appropriate support upon discharge is crucial.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Need for Drug Monitoring</strong>: While some level of monitoring is advisable when a patient is on imipramine, especially for tricyclic antidepressant (TCA) blood levels in certain cases, it is not typically the primary concern at discharge for depression treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ECG Monitoring for Arrhythmias</strong>: Although TCAs like imipramine can have cardiac side effects, including arrhythmias, and may warrant ECG monitoring, particularly in older adults or those with pre-existing heart conditions, it&#39;s not usually the primary concern at the point of discharge unless the patient has a known cardiac issue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sedation Being the Side Effect</strong>: While sedation can be a side effect of imipramine, it is generally not the main concern at discharge. The more pressing issue is the patient&#39;s mental health stability and safety.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The main concern when discharging a patient treated with imipramine for a major depressive episode is the risk of suicide. This requires ensuring that the patient has a safe environment, a follow-up plan, and appropriate support to manage their mental health effectively after discharge.</span></span></span></p>",
    "correct_choice_id": 27870,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6976,
    "choices": [
      {
        "id": 27872,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B and C</span></span></span></p>"
      },
      {
        "id": 27873,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and C only</span></span></span></p>"
      },
      {
        "id": 27874,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B only</span></span></span></p>"
      },
      {
        "id": 27875,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and D</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs are used for absence seizures? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Carbamazepine</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Valproate</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Ethosuximide</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Gabapentin</span></span></span></p>",
    "unique_key": "Q4915448",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306195,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. B and C only</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first line drugs for treatment of absence seizures are valproate and ethosuximide. Carbamazepine and phenytoin are contra-indicated in absence seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs Used in Absence Seizures</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethosuximide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is specific for absence seizures. It works by blocking T-type calcium channels in the thalamus, which are believed to play a role in the generation of absence seizures.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproic Acid (Valproate)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Valproate is effective in treating a wide range of seizure types, including absence seizures. It works by increasing GABA levels and blocking sodium and calcium channels. Valproate is also used for bipolar disorder and migraine prophylaxis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Carbamazepine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine is not used for absence seizures. In fact, it can exacerbate absence seizures. It is typically used for partial seizures and generalized tonic-clonic seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Gabapentin: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gabapentin is not effective for absence seizures. It is mainly used for neuropathic pain and as an adjunctive treatment for partial seizures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DRUGS USED IN ABSENCE SEIZURES</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154357.jpg\" style=\"height:412px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 27873,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6979,
    "choices": [
      {
        "id": 27884,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1 B-2 C-3</span></span></span></p>"
      },
      {
        "id": 27885,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2 B-1 C-3</span></span></span></p>"
      },
      {
        "id": 27886,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3 B-2 C-1</span></span></span></p>"
      },
      {
        "id": 27887,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1 B-3 C-2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following dilution of adrenaline and its use? (</span></span>INICET Nov 2020)</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154726.jpg\" style=\"height:239px; width:700px\" /></p>",
    "unique_key": "Q4982983",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306196,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. A-2 B-1 C-3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilutions of adrenaline (epinephrine) with their typical uses:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1:1000&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">dilution of adrenaline is more concentrated and is commonly used in the treatment of <strong>Anaphylaxis</strong>. It is administered intramuscularly in emergency situations for its rapid vasoconstrictive and bronchodilating effects.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1:10000&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dilution is less concentrated and is typically used in the management of <strong>Cardiac Arrest</strong>. It&#39;s administered intravenously.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1:100000&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dilution is used as an additive in <strong>Local Anesthesia</strong>. The vasoconstrictive properties of adrenaline help to prolong the action of the local anesthetic and reduce bleeding in the surgical field.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-154955.jpg\" style=\"height:487px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 27885,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6981,
    "choices": [
      {
        "id": 27892,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-3, C-4, D-2</span></span></span></p>"
      },
      {
        "id": 27893,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-1, C-4, D-3</span></span></span></p>"
      },
      {
        "id": 27894,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-1, D-2</span></span></span></p>"
      },
      {
        "id": 27895,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-2, D-3</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following bacteria with the drug of choice used for each? (</span></span>INICET Nov 2020)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-160007.jpg\" style=\"height:358px; width:700px\" /></span></span></span></p>",
    "unique_key": "Q4690554",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306197,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. A-2, B-1, C-4, D-3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vancomycin is Drug of Choice for Methicillin-Resistant Staphylococcus aureus (MRSA) &ndash; It acts by inhibiting the cell wall synthesis and is a bactericidal drug.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metronidazole drug of choice against anaerobic infections caused by Bacteroides.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Meropenem is used in infections caused by Klebsiella. Klebsiella is known to produce ESBL (Extended Spectrum Beta Lactamases). Carbapenems are not hydrolyzed by ESBL. Therefore, carbapenems like imipenem, meropenem, ertapenem are indicated in the treatment of infections caused by ESBL producing bacteria. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Penicillin like amoxicillin, ampicillin can be used in H. influenzae infections.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the drug of choice for anaerobic infections caused by <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacteroides</span></strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the drug of choice for infections caused by <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRSA</span></strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Penicillins&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">like amoxicillin and ampicillin are used for <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haemophilus influenzae</span></strong> infections.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meropenem&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is used for infections caused by <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Klebsiella</span></strong>, particularly ESBL-producing strains.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 27893,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6982,
    "choices": [
      {
        "id": 27896,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B and C</span></span></span></p>"
      },
      {
        "id": 27897,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and B</span></span></span></p>"
      },
      {
        "id": 27898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only A</span></span></span></p>"
      },
      {
        "id": 27899,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B, C</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug reduces mortality in COVID-19 patients? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Dexamethasone</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Remdesivir</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Favipiravir</span></span></span></p>",
    "unique_key": "Q4434726",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306198,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Only A</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In severe COVID-19 infection, there is a systemic inflammatory response, which can lead to lung injury and multiple organ dysfunction. Corticosteroids, due to their anti-inflammatory effect, can help mitigate these negative effects and reduce the mortality in patients.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only dexamethasone has been shown to reduce mortality in severe covid19 cases.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone 6 mg IV/PO once daily for 10 days or until hospital discharge is given in severe cases. In the absence of dexamethasone, equivalent doses of other corticosteroids such as prednisone, methylprednisone, or hydrocortisone may be used.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Remdesivir</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Remdesivir is an antiviral drug that inhibits viral RNA polymerase.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usage</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is used to reduce the duration of illness in COVID-19 patients, but it has not been conclusively shown to reduce mortality.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Favipiravir</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Favipiravir is an antiviral drug that inhibits viral RNA polymerase.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usage</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is used in some countries for the treatment of COVID-19, but there is no strong evidence to support a reduction in mortality.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the only drug among the listed options that has been shown to reduce mortality in severe COVID-19 cases, due to its potent anti-inflammatory effects. Remdesivir and favipiravir have not demonstrated a mortality benefit.</span></span></span></p>",
    "correct_choice_id": 27898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6984,
    "choices": [
      {
        "id": 27904,
        "text": "<p><span style=\"font-size:12pt;\">A and C</span></p>"
      },
      {
        "id": 27905,
        "text": "<p><span style=\"font-size:12pt;\">A, B and C</span></p>"
      },
      {
        "id": 27906,
        "text": "<p><span style=\"font-size:12pt;\">A and D</span></p>"
      },
      {
        "id": 27907,
        "text": "<p><span style=\"font-size:12pt;\">B, C and D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following statements are true? (</span>INICET Nov 2020)</p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:12pt;\">Morphine is used for treatment of pulmonary oedema</span></li><li><span style=\"font-size:12.0pt;\">Pethidine is used for treatment of pain due to biliary colic</span></li><li><span style=\"font-size:12pt;\">Indomethacin can cause headache</span></li><li><span style=\"font-size:12pt;\">Aspirin is used for treatment of peptic ulcer disease</span></li></ol>",
    "unique_key": "Q2406122",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306199,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. A and C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aspirin can actually exacerbate peptic ulcer disease due to its mechanism of inhibiting prostaglandin production, which is protective for the gastric mucosa. It is more commonly associated with causing or worsening gastric ulcers rather than treating them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>A.</strong> <strong>Morphine is used for treatment of pulmonary edema</strong>: Morphine can be used in the acute management of pulmonary edema, particularly when it's due to heart failure. It reduces preload and afterload on the heart and can alleviate the associated anxiety and discomfort. However, its use has become less common due to concerns about potential side effects, including respiratory depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>C.</strong> <strong>Indomethacin can cause headache</strong>: This is true. While Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and fever, one of its side effects can be headache.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>B.</strong> <strong>Pethidine is used for treatment of pain due to biliary colic</strong>: Pethidine (Meperidine) is generally not recommended for biliary colic because it can cause spasm of the sphincter of Oddi, potentially worsening pain in biliary </span><span style=\"font-size:12.0pt;\">coli due to its anticholinergic property.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>D. Aspirin is used for treatment of peptic ulcer disease</strong>: This is false. Aspirin can actually exacerbate peptic ulcer disease due to its mechanism of inhibiting prostaglandin production, which protects the gastric mucosa. Aspirin is more commonly associated with causing or worsening gastric ulcers rather than treating them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Morphine can be used for the treatment of pulmonary edema, and indomethacin can cause headaches.</span></li><li><span style=\"font-size:12pt;\">Aspirin is not used for the treatment of peptic ulcer disease and can actually worsen it. While opioids can be used for biliary colic, their use is not without complications, and not all opioids are appropriate for this condition.</span></li></ul>",
    "correct_choice_id": 27904,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6986,
    "choices": [
      {
        "id": 27912,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B &amp; C</span></span></span></p>"
      },
      {
        "id": 27913,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A, B, C &amp; D</span></span></span></p>"
      },
      {
        "id": 27914,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A &amp; B</span></span></span></p>"
      },
      {
        "id": 27915,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C &amp; D</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is correct about the drugs used in Gout? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Aspirin is not used as it decreases the uric acid excretion</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Diclofenac is used as it concentrates in the joint</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Indomethacin is used as it acts by multiple pathways</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Aspirin is used as it is most powerful NSAID</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
    "unique_key": "Q2943328",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306200,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. A, B &amp; C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin is not used as it decreases the uric acid excretion</strong>: This statement remains correct. Aspirin at low doses can decrease uric acid excretion, potentially worsening gout. Therefore, it is generally not recommended in the management of gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diclofenac is used as it concentrates in the joint</strong>: Diclofenac is commonly used in the management of gout due to its anti-inflammatory properties. It gets concentrated in joints and its effect in reducing inflammation and pain in gout is beneficial.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Indomethacin is used as it acts by multiple pathways</strong>: Indomethacin is indeed used in the treatment of gout. It is an NSAID that works by inhibiting the production of prostaglandins. It has multiple pathways of action including inhibition of COX and decrease in rate of phagocytosis of urate crystals. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin is used as it is the most powerful NSAID</strong>: This statement is incorrect for reasons previously mentioned. Aspirin, particularly at low doses, is not recommended for gout due to its potential to increase serum uric acid levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The preferred treatment for an acute gout attack is an NSAID (nonsteroidal anti-inflammatory drug), such as indomethacin. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A typical first-line treatment for gout is indomethacin. Besides suppressing prostaglandin synthesis, indomethacin and other NSAIDs also reduce rate of crystal phagocytosis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Furthermore, intraarticular steroids like methylprednisolone or triamcinolone may be given.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin is not utilized because it promotes renal retention of uric acid.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 27912,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6987,
    "choices": [
      {
        "id": 27916,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 4</span></span></span></p>"
      },
      {
        "id": 27917,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3 </span></span></span></p>"
      },
      {
        "id": 27918,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 3 </span></span></span></p>"
      },
      {
        "id": 27919,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 only</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs exacerbates myasthenia and is usually avoided in a patient with myasthenia gravis? (</span></span></span>INICET Nov 2020)</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Lidocaine </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. Aspirin </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Meropenem </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Phenytoin </span></span> </span></span></span></p>",
    "unique_key": "Q9990150",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306201,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. 1 and 4</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Lidocaine can exacerbate myasthenia gravis and should be used with caution in patients with this disease. Lidocaine can cause neuromuscular blockade, which can worsen the muscle weakness and fatigue associated with myasthenia gravis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Phenytoin is an antiepileptic drug that can cause neuromuscular blockade, which can exacerbate the muscle weakness and fatigue associated with myasthenia gravis. Therefore, it is generally avoided in patients with this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. Aspirin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Aspirin is an anti-inflammatory and antiplatelet drug. It does not have neuromuscular blocking properties and does not exacerbate myasthenia gravis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use in Myasthenia Gravis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Aspirin is generally safe for use in myasthenia gravis patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Meropenem</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Meropenem is a broad-spectrum antibiotic. While some antibiotics can interfere with neuromuscular transmission, meropenem is not typically associated with exacerbating myasthenia gravis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Use in Myasthenia Gravis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Meropenem is usually considered safe for use in myasthenia gravis patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DRUGS THAT SHOULD BE AVOIDED IN MYSTHENIA GRAVIS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-161810.jpg\" style=\"height:818px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 27916,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7060,
    "choices": [
      {
        "id": 28208,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Andexanet alfa: Edoxaban</span></span></span></p>"
      },
      {
        "id": 28209,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Andexanet alfa: Rivaroxaban</span></span></span></p>"
      },
      {
        "id": 28210,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Idarucizumab: Dabigatran</span></span></span></p>"
      },
      {
        "id": 28211,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciraparantag: Fondaparinux</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a correct match regarding FDA approved antidotes of anticoagulants? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q4939172",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306202,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Ciraparantag: Fondaparinux</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">FDA-approved antidotes for specific anticoagulants are designed to counteract the effects of these drugs in cases of excessive bleeding or when rapid reversal is required for surgery or other urgent medical situations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ciraparantag is a broad-spectrum antidote that has shown effectiveness against various anticoagulants, including dabigatran, oral factor Xa inhibitors, low molecular weight heparins (LMWH), unfractionated heparin (UFH), and fondaparinux. However, it is important to note that Ciraparantag is not currently FDA-approved for these indications.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Andexanet alfa: Edoxaban</strong>: Andexanet alfa is an FDA-approved antidote for oral factor Xa inhibitors, including Edoxaban, Apixaban, and Rivaroxaban. It works by binding to and sequestering the factor Xa inhibitors, thus reversing their anticoagulant effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Andexanet alfa: Rivaroxaban</strong>: Similarly, Andexanet alfa is also the antidote for Rivaroxaban, a factor Xa inhibitor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Idarucizumab: Dabigatran</strong>: Idarucizumab is a monoclonal antibody that specifically binds to Dabigatran, an oral direct thrombin inhibitor, and neutralizes its anticoagulant effect. This antidote is FDA-approved.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Andexanet alfa is the approved antidote for oral factor Xa inhibitors like Edoxaban and Rivaroxaban, while Idarucizumab is the antidote for Dabigatran. Although Ciraparantag has shown promise as a broad-spectrum antidote, it is not FDA-approved for use with fondaparinux or other anticoagulants.</span></span></span></p>",
    "correct_choice_id": 28211,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7061,
    "choices": [
      {
        "id": 28212,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Labile hypertension</span></span></span></p>"
      },
      {
        "id": 28213,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary hypertension</span></span></span></p>"
      },
      {
        "id": 28214,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of resistant migraine</span></span></span></p>"
      },
      {
        "id": 28215,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistant Parkinson&#39;s disease</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhaled Nitric oxide is approved for treatment of? (</span></span>INICET May 2021)</p>",
    "unique_key": "Q6194604",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306203,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pulmonary hypertension</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide (NO) has specific clinical applications, particularly in the field of pulmonary medicine. It is approved for the treatment of pulmonary hypertension, especially in certain acute settings. It works by selectively dilating the pulmonary vessels by increasing cyclic guanosine monophosphate (cGMP), thereby reducing pulmonary artery pressure and improving oxygenation. Inhaled nitric oxide is particularly noted for its use in newborns with hypoxic respiratory failure associated with pulmonary hypertension. It can also be used in the acute management of pulmonary hypertension in adults during cardiac surgery or critical care settings.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Labile Hypertension</strong>: Inhaled nitric oxide is not used for the treatment of labile hypertension. Hypertension is typically managed with systemic medications rather than inhaled agents.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of Resistant Migraine</strong>: Inhaled nitric oxide is not a standard treatment for migraines, whether typical or resistant. Migraine treatment usually involves a range of other pharmacological interventions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Resistant Parkinson&#39;s Disease</span></strong><span style=\"font-size:12.0pt\">: There is no established role for inhaled nitric oxide in the treatment of Parkinson&rsquo;s disease. Parkinson&#39;s disease management primarily involves medications that affect dopamine pathways.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other uses of inhaled Nitric Oxide:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neonatal Care</span></strong><span style=\"font-size:12.0pt\">: It is particularly valuable in the treatment of newborns with persistent pulmonary hypertension of the newborn (PPHN) to improve oxygenation.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS)</span></strong><span style=\"font-size:12.0pt\">: While its benefits in ARDS in adults are still a subject of research and debate, it has been used for its pulmonary vasodilator effects in some critical care settings.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cardiac Surgery</span></strong><span style=\"font-size:12.0pt\">: Inhaled NO can be used during cardiac surgery to control pulmonary artery pressures.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lung Transplantation</span></strong><span style=\"font-size:12.0pt\">: It may be used to reduce pulmonary hypertension and improve graft function immediately after transplantation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inhaled Nitric Oxide is approved for the treatment of pulmonary hypertension, particularly in acute settings to reduce pulmonary artery pressure and improve oxygenation. It is not used for labile hypertension, migraines, or Parkinson&#39;s disease.</span></span></span></p>",
    "correct_choice_id": 28213,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7063,
    "choices": [
      {
        "id": 28220,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      },
      {
        "id": 28221,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medulloblastoma</span></span></span></p>"
      },
      {
        "id": 28222,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pleuropulmonary blastoma</span></span></span></p>"
      },
      {
        "id": 28223,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nivolumab is used as a checkpoint inhibitor in?</span></span></p>",
    "unique_key": "Q6758896",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306204,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Hodgkin&#39;s lymphoma</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab is a monoclonal antibody that works as an immune checkpoint inhibitor by blocking the interaction between PD-1 on the surface of T cell and its ligand present on the tumor cell. It is used in the treatment of Non-small cell lung cancer, Hodgkin&rsquo;s Lymphoma, Advanced melanoma and advanced head and neck cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Retinoblastoma</strong>: Nivolumab is not typically used for the treatment of retinoblastoma, which is a rare type of eye cancer that usually develops in early childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Medulloblastoma</strong>: This is a type of brain cancer more common in children. Nivolumab is not a standard treatment for medulloblastoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>Pleuropulmonary blastoma</strong>: This is a rare type of cancer that starts in the lung or pleural cavity, mostly affecting children. Nivolumab is not indicated for this cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab is an immune checkpoint inhibitor used for the treatment of Hodgkin&rsquo;s lymphoma, among other cancers such as non-small cell lung cancer, advanced melanoma, and advanced head and neck cancer. It works by blocking the PD-1/PD-L1 interaction, thereby enhancing the immune response against cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immune check point inhibitors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ew: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>ivolumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rugs: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>urvalumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ct: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>velumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>At</strong>ezolizumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mmune: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>I</strong>pilimumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">heck: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>C</strong>emiplimab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oint: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>P</strong>embrolizumab</span></span></span></p>",
    "correct_choice_id": 28223,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7064,
    "choices": [
      {
        "id": 28224,
        "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Presence of benzalkonium bromide in the preparation</span></p>"
      },
      {
        "id": 28225,
        "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Prejunctional M2 receptor stimulation</span></p>"
      },
      {
        "id": 28226,
        "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Associated use of hypertonic saline in nebulizer</span></p>"
      },
      {
        "id": 28227,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Presence of EDTA as impurity</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">All of the following can be the mechanism for paradoxical bronchoconstriction seen with the use of ipratropium bromide Except? (</span>INICET May 2021)</p>",
    "unique_key": "Q1103579",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306205,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prejunctional M2 receptor stimulation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Pre-synaptic muscarinic M2 receptors inhibit the release of acetylcholine which is a potent bronchoconstrictor. Therefore, presynaptic stimulation of these receptors will result in bronchodilation, not constriction. On the other hand, ipratropium can cause transient bronchoconstriction initially, one the reason is blockade (not stimulation) of the pre-synaptic receptors resulting in more release of acetylcholine.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Paradoxical bronchoconstriction&nbsp;with ipratropium bromide, particularly when given by nebulizer, were largely explained as:</span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Effects of the hypertonic nebulizer solution</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Antibacterial additives, such as benzalkonium chloride and EDTA.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Presynaptic blockade (not stimulation) of muscarinic (M2) receptors</span></p></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This problem has not been described with tiotropium bromide or other LAMAs.</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Presence of benzalkonium bromide in the preparation</strong>: Benzalkonium bromide is a preservative that can cause bronchoconstriction in susceptible individuals when used in nebulized medications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Associated use of hypertonic saline in nebuliser</strong>: Hypertonic saline can irritate the airways and lead to bronchoconstriction, which can explain paradoxical reactions during nebulization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Presence of EDTA as impurity</strong>: EDTA, used as a stabilizing agent in some formulations, can also cause bronchoconstriction by irritating the airways</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Paradoxical bronchoconstriction associated with ipratropium bromide is not caused by prejunctional M2 receptor stimulation. Instead, it can be caused by the presence of benzalkonium bromide, use of hypertonic saline, and presence of EDTA as impurities, which can all irritate the airways and lead to bronchoconstriction.</span></p>",
    "correct_choice_id": 28225,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7066,
    "choices": [
      {
        "id": 28232,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonorrhea</span></span></span></p>"
      },
      {
        "id": 28233,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      },
      {
        "id": 28234,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intra-abdominal infections</span></span></span></p>"
      },
      {
        "id": 28235,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malaria</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antimicrobial combinations are used in all except? (</span></span>INICET May 2021)</p>",
    "unique_key": "Q7904762",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306206,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Gonorrhea</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug of choice for treatment of gonorrhea is single dose ceftriaxone therapy. It does not require combination therapy. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For Management of <strong>Tuberculosis</strong>, a combination of drugs consisting of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol are used. In cases like MDR or XDR TB, other drugs like Bedaquiline, Levofloxacin, Ethionamide etc. are used in various combinations and in the form of different regimens.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Intraabdominal infections</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are generally polymicrobial in nature consisting of both aerobic and anaerobic microorganisms. Combination therapy with metronidazole and other agents like ciprofloxacin, cefepime, etc. are used as empirical agents to treat them.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Malaria:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In case of Plasmodium vivax infection, Chloroquine is used for 3 days + Primaquine is added for 14 days. For P. Falciparum infection, combination therapy consisting of ACT-SP (Artesunate + Sulfadoxine + Pyrimethamine) are used along with a single dose of Primaquine on Day 2. For P. Falciparum infection in the north eastern states, ACT-AL (Artemether + Lumefantrine) is used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antimicrobial combination therapy is not used for the treatment of gonorrhea, which is typically managed with single-dose ceftriaxone therapy. In contrast, tuberculosis, intra-abdominal infections, and malaria require combination therapy to effectively manage the infections and prevent resistance.</span></span></span></p>",
    "correct_choice_id": 28232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7068,
    "choices": [
      {
        "id": 28240,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      },
      {
        "id": 28241,
        "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
      },
      {
        "id": 28242,
        "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
      },
      {
        "id": 28243,
        "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the site of action of vancomycin&nbsp;as shown in &nbsp;the image below</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/2-1.jpg\" alt=\"\" width=\"500\" height=\"402\"></span></p>",
    "unique_key": "Q6131456",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306207,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vancomycin is a cell wall synthesis inhibitor. It binds to the D-Ala-D-Ala terminus of the newly formed peptidoglycan pentapeptide. This prevents further elongation of the peptidoglycan and its cross-linking by inhibiting transglycolase. Therefore, in the above given image, it acts at the step 4. Vancomycin is a bactericidal agent used against gram positive bacteria.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Option A. 1</strong>: Fosfomycin inhibits step 1 in the image. It inhibits the cytoplasmic enzyme enol pyruvate transferase that catalyses the initial step in the bacterial cell wall synthesis. It is used for the treatment of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 2</strong>: It is inhibited by Cycloserine.</span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">It is a structural analog of D-alanine and inhibits the enzymes alanine racemase that converts L-alanine to D-alanine and d-alanyl-d-alanine ligase, thereby preventing the incorporation of D-alanine into the peptidoglycan chain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;3</strong>: Bacitracin inhibits step 3 in the image. It is a cell wall synthesis inhibitor that interferes with dephosphorylation of the BP transporter which transfers peptidoglycan subunits to the growing cell wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vancomycin acts at step 4 in the bacterial cell wall synthesis process by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, thereby inhibiting further elongation and cross-linking of the peptidoglycan.</span></p>",
    "correct_choice_id": 28243,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7070,
    "choices": [
      {
        "id": 28248,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life doubles and plasma concentration remains the same</span></span></span></p>"
      },
      {
        "id": 28249,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life remains the same and plasma concentration doubles</span></span></span></p>"
      },
      {
        "id": 28250,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life and plasma concentration remains the same</span></span></span></p>"
      },
      {
        "id": 28251,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life and plasma concentration doubles</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What would happen to the half-life and plasma concentration of a drug which follows first-order kinetics, if the dose is doubled? (</span></span>INICET May 2021)</p>",
    "unique_key": "Q5807094",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306208,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Half-life remains the same and plasma concentration doubles</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In case of drugs following 1<sup>st</sup> order kinetics, a constant fraction of the drug is eliminated in a given time. Therefore, the half-life of the drug remains constant and the Clearance also remains constant.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Key points regarding first-order kinetics:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Half-life remains constant</span></strong><span style=\"font-size:12.0pt\">: The half-life of the drug does not change with the dose. It remains constant because the fraction of the drug eliminated per unit time is constant.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clearance remains constant</span></strong><span style=\"font-size:12.0pt\">: The clearance, which is the volume of plasma from which the drug is completely removed per unit time, remains constant.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Plasma concentration</span></strong><span style=\"font-size:12.0pt\">: When the dose is doubled, the plasma concentration of the drug also doubles because the rate of elimination is proportional to the concentration of the drug in the plasma.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For drugs following first-order kinetics, The rate of elimination of the drug is directly proportional its plasma concentration. So, when the dose is doubled for a drug following first order kinetics, the plasma concentration is also doubled.</span></span></span></p>",
    "correct_choice_id": 28249,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7073,
    "choices": [
      {
        "id": 28260,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OCD</span></span></span></p>"
      },
      {
        "id": 28261,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dementia</span></span></span></p>"
      },
      {
        "id": 28262,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PTSD</span></span></span></p>"
      },
      {
        "id": 28263,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bipolar disorder</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an off-label use of risperidone? (</span></span>INICET May 2021)</p>",
    "unique_key": "Q1129055",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306209,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Bipolar disorder</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Off-label drug use refers to the prescription of a medication for a condition that is not included in its approved labeling by the Food and Drug Administration (FDA). </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Risperidone is FDA-approved for the treatment of bipolar disorder. It is specifically approved for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder, both as monotherapy and as an adjunct to lithium or valproate.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Other Options:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>A.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>OCD (Obsessive-Compulsive Disorder)</strong>: The use of risperidone for OCD is generally considered off-label. While antipsychotics like risperidone can be used adjunctively in treatment-resistant OCD, it&#39;s not an FDA-approved indication.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>B.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>Dementia</strong>: Using risperidone for the treatment of behavioral symptoms in dementia is off-label. Although it&#39;s sometimes prescribed for this purpose, it&#39;s important to note that the FDA has issued a black box warning about the increased risk of death when using antipsychotic drugs in elderly patients with dementia-related psychosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>C.</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\"><strong>PTSD: (Post-Traumatic Stress Disorder)</strong>: The use of risperidone in PTSD is also off-label. It has been studied and used for managing certain symptoms of PTSD, but it is not an FDA-approved indication for this condition.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#202122\">Educational Objective:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risperidone is FDA-approved for the treatment of bipolar disorder, making it a labeled use. In contrast, the use of risperidone for OCD, dementia, and PTSD are off-label indications.</span></span></span></p>",
    "correct_choice_id": 28263,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7074,
    "choices": [
      {
        "id": 28264,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">20.8 hours</span></span></span></p>"
      },
      {
        "id": 28265,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6.9 hours</span></span></span></p>"
      },
      {
        "id": 28266,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">13.8 hours</span></span></span></p>"
      },
      {
        "id": 28267,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">9.8 hours</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The elimination rate constant of a drug is 0.05 hr. What is its half-life?&nbsp;</span></span>(INICET MAY 2021)</p>",
    "unique_key": "Q3101653",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306210,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. 13.8 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life is the time in which the plasma concentration of the drug becomes half.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The elimination rate constant of a drug reflects the fraction of drug that is removed from the body compartment per unit time.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The elimination rate constant = k = 0.05 hr.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Half-life = t1/2 = 0.693/k</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore t1/2 = 0.693/0.05 =13.8 hrs.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The half-life of a drug with an elimination rate constant of 0.05 hr is 13.8 hours, calculated using the formula t<sub>1/2</sub>=0.693/k</span></span></span></p>",
    "correct_choice_id": 28266,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7075,
    "choices": [
      {
        "id": 28268,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30 minutes</span></span></span></p>"
      },
      {
        "id": 28269,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">60 minutes</span></span></span></p>"
      },
      {
        "id": 28270,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">90 minutes</span></span></span></p>"
      },
      {
        "id": 28271,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">120 minutes</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is on phenytoin for a seizure disorder. He was prescribed sucralfate 4 times a day for peptic ulcers. What should be the minimum duration of time between consumption of these drugs? (</span></span>INICET May 2021)</p>",
    "unique_key": "Q7671466",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306211,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 120 minutes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sucralfate is made up of aluminium octosulphate of sucrose. In the acidic pH of the stomach, it gets polymerized into a viscous fluid which adheres to the base of the ulcer for upto 6 hours. However, this viscous layer prevents the absorption of other drugs like phenytoin, ketoconazole, fluoroquinolones etc. from the stomach. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a patient is taking both phenytoin (an antiepileptic drug) and sucralfate (a medication used to treat peptic ulcers), it&#39;s important to manage the timing of these medications to avoid drug interactions. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sucralfate can interfere with the absorption of phenytoin when taken too closely together, leading to reduced effectiveness of phenytoin.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The general recommendation is to separate the administration of these two drugs by at least 2 hours. This separation allows sufficient time for the phenytoin to be absorbed before the sucralfate is taken, which can bind to drugs in the gastrointestinal tract and hinder their absorption.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The minimum duration of time between the consumption of phenytoin and sucralfate should be at least 120 minutes (2 hours) to ensure that phenytoin is adequately absorbed and to avoid interactions that could reduce its effectiveness.</span></span></span></p>",
    "correct_choice_id": 28271,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7093,
    "choices": [
      {
        "id": 28340,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bebtelovimab</span></span></span></p>"
      },
      {
        "id": 28341,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Voxelotor</span></span></span></p>"
      },
      {
        "id": 28342,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydroxyurea</span></span></span></p>"
      },
      {
        "id": 28343,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">L-glutamine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young boy with a history of multiple blood transfusions presents with bone pain for the past 6 months. A peripheral smear showed sickle-shaped RBCs. Which of the following drugs are not used in the treatment of his condition?&nbsp;</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q9435793",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306212,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Bebtelovimab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical features are suggestive of Sickle cell anemia. Voxelotor, hydroxyurea and L-glutamine are used for treatment of sickle cell anemia whereas Bebtelovimab is not used in in this condition. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bebtelovimab is a new monoclonal antibody used for the treatment of COVID-19. It works by binding to the spike protein of the COVID-19 virus. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Voxelotor:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Is an inhibitor of hemoglobin S polymerase and stabilizer of sickle cell hemoglobin (HbS) that is used in the therapy of sickle cell disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Hydroxyurea:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Improves fetal hemoglobin (HbF) and is the primary drug for controlling HbS in sickle cell disease. Thus, improving the oxygen-carrying capacity of the blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. L-glutamine:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;Is a naturally occurring amino acid with antioxidant properties. It increases the availability of reduced glutathione which may lessen oxidative damage in sickle red blood cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bebtelovimab is not used in the treatment of sickle cell anemia; it is a monoclonal antibody used for COVID-19 treatment. In contrast, Voxelotor, Hydroxyurea, and L-glutamine are used in managing sickle cell anemia by improving hemoglobin function and reducing oxidative stress in red blood cells.</span></span></span></p>",
    "correct_choice_id": 28340,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7094,
    "choices": [
      {
        "id": 28344,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">48 hours</span></span></span></p>"
      },
      {
        "id": 28345,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">70 hours</span></span></span></p>"
      },
      {
        "id": 28346,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">90 hours</span></span></span></p>"
      },
      {
        "id": 28347,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">120 hours</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The half-life of letrozole is:&nbsp;</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q1005144",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306213,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 48 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The half-life of letrozole is 48 hours.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Letrozole is an aromatase inhibitor which is used in the treatment of ER +ve breast cancers in post-menopausal women. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is also the DOC for treating infertility due to anovulation in PCOS.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The half-life of letrozole is 48 hours. It is an aromatase inhibitor used in the treatment of ER+ breast cancer in post-menopausal women and as the drug of choice for treating infertility due to anovulation in women with PCOS.</span></span></span></p>",
    "correct_choice_id": 28344,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7095,
    "choices": [
      {
        "id": 28348,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1</span></span></span></span></span></p>"
      },
      {
        "id": 28349,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2</span></span></span></span></span></p>"
      },
      {
        "id": 28350,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3</span></span></span></span></span></p>"
      },
      {
        "id": 28351,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4</span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given diagram shows the steps in bacterial cell wall formation. Identify the site of action of beta-lactam antibiotics.</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (INICET MAY 2022)</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/5-1.jpg\" style=\"height:402px; width:500px\" /></span></span></span></span></p>",
    "unique_key": "Q9137622",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306214,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. 4 </span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta lactams act on step 4 in the given image.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The beta lactams inhibit the formation of bacterial cell wall by inhibiting the Transpeptidase enzyme which is required for the cross linking of the peptidoglycan chains; therefore, they lead to a reduction in the strength of the bacterial cell wall which ultimately causes it to burst, leading to the death of the bacteria.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1:&nbsp;</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fosfomycin inhibits step 1 in the image. It inhibits the cytoplasmic enzyme enol pyruvate transferase that catalyses the initial step in the bacterial cell wall synthesis. It is used for the treatment of urinary tract infections.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 2:&nbsp;</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacitracin inhibits step 2 in the image. It is a cell wall synthesis inhibitor that interferes with dephosphorylation of the BP transporter which transfers peptidoglycan subunits to the growing cell wall. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 3:&nbsp;</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin inhibits step 3 in the image. It binds to the D-Ala-D-Ala terminus of the newly formed peptidoglycan pentapeptide. This prevents further elongation of the peptidoglycan and its cross-linking by inhibiting transglycolase. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-lactam antibiotics act at step 4 in the bacterial cell wall synthesis process by inhibiting transpeptidase enzymes, which are essential for cross-linking peptidoglycan chains, thereby weakening the bacterial cell wall and causing cell lysis.</span></span></span></span></p>",
    "correct_choice_id": 28351,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7096,
    "choices": [
      {
        "id": 28352,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gs</span></span></span></p>"
      },
      {
        "id": 28353,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gi</span></span></span></p>"
      },
      {
        "id": 28354,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gq</span></span></span></p>"
      },
      {
        "id": 28355,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Go</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phospholipase C acts via which of the following G protein-coupled receptors?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q1289577",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306215,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Gq&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phospholipase C acts via the Gq type of G protein-coupled receptors. It leads to the activation of the IP3-DAG pathway. The receptors that act via this pathway include the receptors of H1, &alpha;1, M1, V1, M3, Angiotensin II, Gastrin, GnRH, Oxytocin and TRH.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Important points about GPCR:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G protein-coupled receptors (GPCRs) are cell membrane receptors that span across the membrane 7 times (heptahelical). Subtypes of GPCRs are distinguished by their alpha subunits. The important subtypes of GPCRs are Gs, Gp, Gq, and Go. GPCRs act via various second messengers. The important ones with their action on the effector are:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gs causes activation of adenylyl cyclase and thus increase in cAMP.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gi causes inhibition of adenylyl cyclase and thus decrease in cAMP.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Go causes Ca2+ channel inhibition.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gq causes activation of phospholipase C which generates the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). It helps in mobilizing Ca<sup>2+</sup> form the endoplasmic reticulum stores.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phospholipase C (PLC) is activated by Gq-coupled receptors, which in turn generate the second messengers IP3 and DAG, leading to various downstream effects, including the mobilization of calcium ions from intracellular stores.</span></span></span></p>",
    "correct_choice_id": 28354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7097,
    "choices": [
      {
        "id": 28356,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid\ufeff\ufeff\ufeff</span></span></span></span></span></p>"
      },
      {
        "id": 28357,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></span></span></span></p>"
      },
      {
        "id": 28358,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffPyrazinamide</span></span></span></span></span></p>"
      },
      {
        "id": 28359,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffEthambutol</span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was diagnosed with pulmonary tuberculosis and was started on first-line antitubercular drugs.</span></span></span> <span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug acts by inhibiting the synthesis of the marked layer shown by arrow in the image?</span></span></span>(INICET MAY 2022)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-170623.png\" style=\"height:321px; width:500px\" /></span></span></span></span></span></p>",
    "unique_key": "Q7106335",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306216,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Isoniazid</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-41px\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid is activated by Catalase Peroxidase and it acts by blocking the mycolic acid synthesis. It is a bactericidal drug that is effective against both intracellular and extracellular bacteria that are actively replicating.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Rifampicin</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is the most bactericidal drug, that is effective against intra as well as extracellular bacteria. It acts by blocking RNA polymerase.</span></span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Pyrazinamide</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is also bactericidal, that is effective mainly against intracellular bacteria. It acts by blocking fatty acid synthase.</span></span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Ethambutol</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is a bacteriostatic 1<sup>st</sup> line anti-tubercular drug that acts against both intra and extracellular bacteria by blocking arabinosyl transferase.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Isoniazid acts by inhibiting the synthesis of mycolic acid, a critical component of the mycobacterial cell wall, making it an effective first-line treatment for tuberculosis. The other first-line drugs have different mechanisms of action, such as inhibiting RNA polymerase (rifampicin), blocking fatty acid synthase (pyrazinamide), and inhibiting arabinosyl transferase (ethambutol).</span></span></span></p>",
    "correct_choice_id": 28356,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7098,
    "choices": [
      {
        "id": 28360,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mydriasis</span></span></span></p>"
      },
      {
        "id": 28361,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diuresis</span></span></span></p>"
      },
      {
        "id": 28362,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscle fasciculations</span></span></span></p>"
      },
      {
        "id": 28363,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bradycardia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A man was brought to the emergency room after poisoning with an unknown substance. Muscarinic poisoning was suspected and he was treated for the same. What is the possible presenting feature which led to the diagnosis?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q8594863",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306217,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Bradycardia</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The types of Muscarinic receptors and their actions are as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M1 &ndash; They increase the acid secretion in the stomach</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M2 &ndash; They are present in the heart and lead to a decrease in heart rate (Bradycardia) and cause slowing of conduction in the AV node.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M3 &ndash; They are present in the respiratory tract and cause bronchoconstriction. They are also present in the urinary bladder, where they help in urination by bringing about contraction of the bladder. In the glands, these receptors help in secretion. In the eyes it leads to miosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bradycardia is the possible presenting feature which led to the diagnosis of muscarinic poisoning in this case. Muscarinic poisoning occurs due to the consumption of poisonous mushroom-like Inocybe. Muscarinic symptoms appear within an hour of eating the mushroom. These symptoms (along with nicotinic symptoms) can also be seen in organophosphate poisoning. Atropine is used for the management of muscarinic poisoning. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><strong><span style=\"font-size:12.0pt\">A</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Mydriasis</strong>: This refers to pupil dilation, which is typically associated with sympathetic stimulation or anticholinergic effects, not muscarinic poisoning.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><span style=\"font-size:12pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Diuresis</strong>: This refers to increased urine production, which is not a direct effect of muscarinic poisoning. Muscarinic activation actually increases bladder contraction, promoting urination.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option </span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Muscle fasciculations</strong>: These are more associated with nicotinic receptor activation, not muscarinic receptor activation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bradycardia is a key presenting feature that can lead to the diagnosis of muscarinic poisoning. Muscarinic receptors, particularly M2 receptors in the heart, mediate a decrease in heart rate. Atropine is used to manage muscarinic poisoning by blocking acetylcholine&#39;s action on these receptors.</span></span></span></p>",
    "correct_choice_id": 28363,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7099,
    "choices": [
      {
        "id": 28364,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
      },
      {
        "id": 28365,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lamotrigine</span></span></span></p>"
      },
      {
        "id": 28366,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oxcarbazepine</span></span></span></p>"
      },
      {
        "id": 28367,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Olanzapine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old lady came to psychiatry OPD with symptoms of hypomania. There is a past history of maniac episode. Now, she is planning to conceive. Which of the following drug is maximum teratogenic to the fetus?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q2511282",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306218,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Valproate </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate is the most teratogenic drug among the drugs used in bipolar disorder and anti-epileptic medications. It causes congenital anomalies like neural tube defects (spina bifida), cleft lip and cleft palate, and cardiac anomalies. It also contributes to poor cognitive development in children.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although lithium is also teratogenic and can cause Ebstein anomaly in the fetus, but it is less teratogenic than valproate.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Lamotrigine</strong>: This medication is also used to treat bipolar disorder and epilepsy, but it has a lower risk of teratogenic effects compared to valproate. The risk of major congenital malformations with lamotrigine is relatively low.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Oxcarbazepine</strong>: Used to treat epilepsy and bipolar disorder, oxcarbazepine has a moderate risk of teratogenic effects, but it is still considered less teratogenic than valproate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Olanzapine</strong>: This antipsychotic medication is used for bipolar disorder and schizophrenia. While there are some risks associated with its use during pregnancy, including potential metabolic complications, it is not considered as teratogenic as valproate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Note on Lithium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Although lithium is also used to treat bipolar disorder and is known to be teratogenic, causing conditions like Ebstein&#39;s anomaly (a heart defect), its teratogenic risk is considered lower than that of valproate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Valproate is the most teratogenic drug among the options listed, causing significant congenital anomalies such as neural tube defects, cleft lip and palate, and cardiac anomalies, as well as poor cognitive development. It should be avoided in women who are planning to conceive or are pregnant.</span></span></span></p>",
    "correct_choice_id": 28364,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7100,
    "choices": [
      {
        "id": 28368,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
      },
      {
        "id": 28369,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3, 4</span></span></span></p>"
      },
      {
        "id": 28370,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
      },
      {
        "id": 28371,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">True statement regarding the administration of 5 alpha-reductase inhibitors is/are: (INICET MAY 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Reduces dihydrotestosterone levels</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Reduces testosterone levels</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Elevates PSA levels</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Decreases PSA levels</span></span></span></p>",
    "unique_key": "Q3724900",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306219,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. 1, 4 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5 alpha-reductase inhibitors, such as finasteride and dutasteride, are used primarily in the treatment of benign prostatic hyperplasia (BPH) and conditions like male pattern baldness and hirsutism. These medications work by inhibiting the enzyme 5 alpha-reductase, which is responsible for converting testosterone into dihydrotestosterone (DHT), a more potent androgen.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Effects of 5 Alpha-Reductase Inhibitors</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reduces Dihydrotestosterone Levels</span></strong><span style=\"font-size:12.0pt\">: By inhibiting the conversion of testosterone to DHT, these drugs significantly lower DHT levels in the body. DHT is a key factor in the development and enlargement of the prostate and also contributes to hair loss.</span></span></span></li>\r\n</ol>\r\n\r\n<ol start=\"4\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Decreases PSA Levels</span></strong><span style=\"font-size:12.0pt\">: Prostate-specific antigen (PSA) levels are often reduced as a result of decreased prostate volume and reduced androgenic stimulation of the prostate. PSA is a marker used to screen for and monitor prostate cancer and other prostate-related conditions.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol start=\"2\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reduces Testosterone Levels</span></strong><span style=\"font-size:12.0pt\">: This statement is incorrect. 5 alpha-reductase inhibitors do not significantly reduce testosterone levels. In fact, due to the reduced conversion to DHT, plasma testosterone levels may remain unchanged or even increase slightly.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Elevates PSA Levels</span></strong><span style=\"font-size:12.0pt\">: This statement is incorrect. These drugs typically decrease PSA levels due to reduced androgenic activity in the prostate.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Uses</span></strong><span style=\"font-size:12.0pt\">: These inhibitors are used alongside surgery and alpha-1 adrenergic blockers for treating BPH. They are also utilized in managing male pattern baldness and hirsutism.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Action</span></strong><span style=\"font-size:12.0pt\">: By competitively inhibiting 5 alpha-reductase, they reduce the production of DHT, which is responsible for stimulating prostate growth and hair loss.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5 alpha-reductase inhibitors are the competitive inhibitors of the enzyme 5 alpha-reductase which converts testosterone into the more active dihydroxy testosterone (DHT). This enzyme inhibition results in:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased DHT levels</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased PSA levels</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces prostate volume</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, plasma testosterone levels remain unchanged or may increase due to non-conversion to DHT. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 28370,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7101,
    "choices": [
      {
        "id": 28372,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drug</span></span></span></p>"
      },
      {
        "id": 28373,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adulterated drug</span></span></span></p>"
      },
      {
        "id": 28374,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unethical drug</span></span></span></p>"
      },
      {
        "id": 28375,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Misbranded drug</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The manufacturer of a drug company labels a drug as having 500 mg paracetamol. On quantitative analysis of the drug, it actually contained only 200 mg of paracetamol. What is this type of drug called? (INICET MAY 2022)</span></span></p>",
    "unique_key": "Q9091530",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306220,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Misbranded drug</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#374151\">A misbranded drug refers to a drug whose labeling is inaccurate or misleading. This includes incorrect labeling of the quantity of active ingredients. In this scenario, where the medication is labeled as containing 500 mg of paracetamol but actually contains only 200 mg, it would be considered a misbranded drug.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spurious drugs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These products are manufactured concealing the true identity of the product and made to resemble another drug, especially some popular brand, to deceive the buyer and cash on the popularity of original product. The product may or may not contain the active ingredients. Spurious drugs are usually manufactured by unlicensed anti-social elements but sometimes licensed manufacturers may also be involved.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Adulterated drugs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> These are those drugs which are found to contain an adulterant/substituted product or contaminated with filth rendering it injurious to health </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.&nbsp;<span style=\"color:#374151\">Unethical drug</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#374151\">: &quot;Unethical drug&quot; is not a standard term in pharmaceutical regulation. The issue here is not primarily about ethics but rather about the accuracy of labeling and drug quality.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug labeled inaccurately with respect to its active ingredient quantity is considered a misbranded drug. Ensuring accurate labeling is crucial for regulatory compliance and consumer safety, as it ensures that drugs on the market are labeled truthfully and can be trusted for their intended use.</span></span></span></p>",
    "correct_choice_id": 28375,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7102,
    "choices": [
      {
        "id": 28376,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rosiglitazone</span></span></span></p>"
      },
      {
        "id": 28377,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liraglutide</span></span></span></p>"
      },
      {
        "id": 28378,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Voglibose</span></span></span></p>"
      },
      {
        "id": 28379,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Canagliflozin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-diabetic drugs is associated with the increased risk of fractures? (INICET MAY 2022)</span></span></p>",
    "unique_key": "Q4573412",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306221,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Rosiglitazone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rosiglitazone, a drug belonging to the class of thiazolidinediones, has been associated with an increased risk of bone fractures. The mechanism behind this is not fully understood, but it is thought that thiazolidinediones might interfere with bone metabolism (PPAR&gamma; agonist), leading to decreased bone mineral density which can increase the risk of fractures, especially in postmenopausal women.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Liraglutide</span></strong><span style=\"font-size:12.0pt\">: It is a&nbsp;GLP-1 receptor agonist used in the treatment of type 2 diabetes. There is no strong evidence linking liraglutide to an increased risk of fractures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Voglibose</span></strong><span style=\"font-size:12.0pt\">: It is an alpha-glucosidase inhibitor which delays the absorption of carbohydrates from the intestines. It has not been primarily associated with an increased risk of fractures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Canagliflozin</span></strong><span style=\"font-size:12.0pt\">: It is one of the&nbsp;SGLT2 inhibitors that works by removing glucose through the urine. While there have been some discussions about bone density changes with SGLT2 inhibitors, canagliflozin specifically has had mixed results in studies regarding fracture risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glitazones like rosiglitazone and pioglitazone are associated with following adverse effects:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatotoxicity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retention of sodium and water</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Risk of osteoporotic fractures</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SGLT-2 inhibitors like canagliflozin is also associated with increased risk of fractures but the incidence is much lower than that with glitazones.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/antidiabetic-agents-for-type-2-diabetes-mellitus-treatment.jpg\" style=\"height:1453px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 28376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7103,
    "choices": [
      {
        "id": 28380,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N - hydroxy cyclophosphamide</span></span></span></p>"
      },
      {
        "id": 28381,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 - hydroxy cyclophosphamide</span></span></span></p>"
      },
      {
        "id": 28382,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 - acetyl cyclophosphamide</span></span></span></p>"
      },
      {
        "id": 28383,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N - acetyl cyclophosphamide</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The active metabolite of cyclophosphamide is: (INICET MAY 2022)</span></span></p>",
    "unique_key": "Q4265125",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306442,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 4 - hydroxy cyclophosphamide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyclophosphamide is an alkylating chemotherapeutic agent whose active metabolite is 4-hydroxy cyclophosphamide.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Side Effects</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemorrhagic Cystitis</span></strong><span style=\"font-size:12.0pt\">: One of the most notable side effects of cyclophosphamide is hemorrhagic cystitis. This is due to the accumulation of the metabolite acrolein in the bladder. To prevent this, mesna (a uroprotective agent) is administered alongside cyclophosphamide, and patients are advised to maintain adequate hydration.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pulmonary Fibrosis</span></strong><span style=\"font-size:12.0pt\">: Another significant side effect is pulmonary fibrosis, which can affect lung function.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bone Marrow Suppression</span></strong><span style=\"font-size:12.0pt\">: Like many chemotherapeutic agents, cyclophosphamide can also cause bone marrow suppression, leading to leukopenia, anemia, and thrombocytopenia.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyclophosphamide&#39;s therapeutic effects are primarily due to its active metabolite, 4-hydroxy cyclophosphamide. It is important to manage the side effects of cyclophosphamide, particularly hemorrhagic cystitis, through the use of mesna and adequate hydration. Pulmonary fibrosis and bone marrow suppression are other significant side effects to be monitored during treatment.</span></span></span></p>",
    "correct_choice_id": 28381,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7104,
    "choices": [
      {
        "id": 28384,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A, B, D</span></span></span></p>"
      },
      {
        "id": 28385,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A, C, D</span></span></span></p>"
      },
      {
        "id": 28386,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A and C</span></span></span></p>"
      },
      {
        "id": 28387,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A and D</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the correct options regarding the route of administration and bioavailability:&nbsp;&nbsp;</span></span></span><span style=\"font-size:15px\"><span style=\"color:black\"><span style=\"font-family:Calibri,sans-serif\">(INICET MAY 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A - Intravenous = 1</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B - 0.75 &lt; Oral &lt;1</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C - 0.75 &lt; IM (</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intramuscular)&nbsp;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;1</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D - 0.75 &lt; SC (Subcutaneous) &lt;1</span></span></span></p>",
    "unique_key": "Q3128147",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306443,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. A, C, D </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To evaluate these options, we need to understand the route of administration and bioavailability for each:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intravenous (IV)</span></strong><span style=\"font-size:12.0pt\">: The bioavailability of a drug administered intravenously is always 1 (or 100%) because it directly enters the systemic circulation without any barriers to absorption.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oral</span></strong><span style=\"font-size:12.0pt\">: The bioavailability of oral medications is typically less than 1 (or 100%) because of the first-pass metabolism (metabolic degradation of a drug before it reaches systemic circulation) and variable absorption in the gastrointestinal tract.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intramuscular (IM)</span></strong><span style=\"font-size:12.0pt\">: The bioavailability of IM administered drugs is typically high but usually less than 1 due to factors like local blood flow and muscle type. It is often close to 1 but not always 100%.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Subcutaneous (SC)</span></strong><span style=\"font-size:12.0pt\">: Similar to IM, the bioavailability of drugs administered subcutaneously is usually high but typically less than 1 due to absorption factors at the injection site.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given this information:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A (Intravenous = 1) is correct.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C (0.75 &lt; IM &lt; 1) is plausible, but like oral administration, the lower limit is not a fixed value.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">D (0.75 &lt; SC &lt; 1) follows the same reasoning as IM; it&#39;s generally true but with a variable lower limit.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">B. (0.75 &lt; Oral &lt; 1) is plausible, although the lower limit of 0.75 is arbitrary and not universally applicable as oral bioavailability can vary widely.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most accurate answer, considering the typical bioavailability ranges for these routes, is B. A, C, D. However, it&#39;s important to note that specific values (like 0.75) provided for oral, IM, and SC routes are not absolute and can vary depending on the drug and other factors.</span></span></span></p>",
    "correct_choice_id": 28385,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7105,
    "choices": [
      {
        "id": 28388,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amlodipine</span></span></span></p>"
      },
      {
        "id": 28389,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide</span></span></span></p>"
      },
      {
        "id": 28390,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Losartan</span></span></span></p>"
      },
      {
        "id": 28391,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Furosemide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A hypertensive patient on medication presents with the lab values as shown below. (</span></span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs should be stopped?</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">K<sup>+</sup> :6.5 meg/L</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Na<sup>+</sup> :137 meg/L</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urea: 42 mg/dL</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine: 3.8 mg/dL</span></span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q9075729",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306444,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp; C. Losartan</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Let&#39;s analyze the lab values and determine which medication, if any, should be stopped:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated Potassium (K<sup>+</sup>): A potassium level of 6.5 mEq/L is higher than the normal range (usually around 3.5 to 5.0 mEq/L). High potassium levels, known as hyperkalemia, can be a concern, especially for patients taking certain medications that can affect potassium levels.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Normal Sodium (Na<sup>+</sup>): A sodium level of 137 mEq/L falls within the normal range. There is no immediate concern regarding sodium levels.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated Urea and Creatinine: Urea and creatinine levels are elevated, indicating impaired kidney function. This is a significant concern, as it may suggest that the kidneys are not effectively filtering waste products from the blood.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Considering the elevated potassium level and impaired kidney function (elevated urea and creatinine), it is important to stop any drug that causes hyperkalemia. Among the given drugs, losartan</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an Angiotensin Receptor Blocker (ARB), which can lead to hyperkalemia by blocking the action of the RAAS pathway. Since this patient has developed Hyperkalemia, Losartan should be stopped.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></strong>: A calcium channel blocker used for hypertension. It does not typically affect potassium levels and does not need to be stopped in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrochlorothiazide</span></strong>: A thiazide diuretic used for hypertension. It usually causes hypokalemia (low potassium levels), not hyperkalemia. Therefore, it does not need to be stopped in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Furosemide</span></strong>: A loop diuretic used to treat edema and hypertension. Furosemide usually causes hypokalemia and can actually be used to help lower elevated potassium levels. Hence, it should not be stopped and might even be beneficial in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a hypertensive patient with hyperkalemia and impaired kidney function, Losartan should be stopped due to its potential to exacerbate hyperkalemia. Amlodipine, hydrochlorothiazide, and furosemide do not typically increase potassium levels and do not need to be stopped. In fact, furosemide may help in lowering the elevated potassium levels.</span></span></span></p>",
    "correct_choice_id": 28390,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7107,
    "choices": [
      {
        "id": 28396,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline</span></span></span></p>"
      },
      {
        "id": 28397,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cevimeline</span></span></span></p>"
      },
      {
        "id": 28398,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarine</span></span></span></p>"
      },
      {
        "id": 28399,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most effective oral drug in smoking cessation?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q3900812",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306445,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Varenicline&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Varenicline is a medication specifically developed to help people quit smoking. It works by partially stimulating </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&alpha;4&beta;2 </span><span style=\"font-size:12.0pt\">nicotine receptors in the brain, which can reduce withdrawal symptoms and cravings associated with quitting smoking. At the same time, it blocks nicotine from attaching to these receptors, making smoking less satisfying. This dual action makes varenicline an effective option for smoking cessation.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The<strong> </strong>Other Options<strong>&nbsp;</strong>listed (B. Cevimeline, C. Muscarine, and D. Atropine) are not typically used for smoking cessation, and their mechanisms of action are not directly related to helping individuals quit smoking.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other drugs used in smoking cessation are bupropion and nicotine replacement therapy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cevimeline</span></strong>: This drug is a muscarinic agonist used to treat dry mouth in patients with Sj&ouml;gren&#39;s syndrome. It is not used for smoking cessation and does not have a mechanism that would help in quitting smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarine</span></strong>: This is a naturally occurring compound that acts as an agonist at muscarinic acetylcholine receptors. It is not used in clinical practice for smoking cessation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></strong>: This is an antimuscarinic agent used to treat bradycardia and for preoperative reduction of saliva. It has no role in smoking cessation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Varenicline is the most effective oral medication for smoking cessation due to its unique mechanism of partially stimulating and blocking nicotine receptors, thereby reducing cravings and the satisfaction derived from smoking. Other drugs like cevimeline, muscarine, and atropine do not have the same efficacy or mechanism for aiding in smoking cessation.</span></span></span></p>",
    "correct_choice_id": 28396,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7108,
    "choices": [
      {
        "id": 28400,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-b, 3-a, 4-c</span></span></span></span></span></p>"
      },
      {
        "id": 28401,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeff1-a, 2-c, 3-d, 4-b</span></span></span></span></span></p>"
      },
      {
        "id": 28402,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">\ufeff\ufeff\ufeff<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-d, 3-b, 4-c</span></span></span></span></span></p>"
      },
      {
        "id": 28403,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeff1-d, 2-c, 3-a, 4-b</span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following antiarrhythmic drugs with their mechanism of action:</span></span></span>(INICET MAY 2022)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-174745.png\" style=\"height:321px; width:700px\" /></span></span></span></span></span></p>",
    "unique_key": "Q2087968",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306446,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 1-a, 2-d, 3-b, 4-c</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct match of antiarrhythmic drugs with their mechanisms of action is as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Na+ channel blocker (Class Ia)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">a. Quinidine</span></strong><span style=\"font-size:12.0pt\">: Quinidine is a Na+ channel blocker with additional potassium channel blocking properties, classifying it as a Class Ia antiarrhythmic drug. It slows phase 0 of the action potential, leading to a prolonged QRS duration.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">K+ channel blocker (Class III)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">d. Ibutilide</span></strong><span style=\"font-size:12.0pt\">: Ibutilide primarily blocks potassium channels, which prolongs repolarization and action potential duration, making it a Class III antiarrhythmic drug.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Na+ K+ ATPase inhibitor</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">b. Digoxin</span></strong><span style=\"font-size:12.0pt\">: Digoxin inhibits the Na+/K+ ATPase pump, leading to an increase in intracellular calcium and positive inotropic effects, which is useful in heart failure and some arrhythmias.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Beta-blocker (Class II)</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">c. Esmolol</span></strong><span style=\"font-size:12.0pt\">: Esmolol is a short-acting beta-blocker that reduces heart rate and myocardial contractility by blocking beta-adrenergic receptors, classifying it as a Class II antiarrhythmic drug.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinidine</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; Na+ Channel Blocker with additional potassium channel blocking property. (class Ia anti-arrhythmic drugs)</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; Na+-K+-ATPase inhibitor.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esmolol</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; &beta; blocker. Belongs to Class II anti arrhythmics.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ibutilide</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &ndash; K+ channel blocker. Class III anti arrhythmics.</span></span></span></span></span></li>\r\n</ol>",
    "correct_choice_id": 28402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7109,
    "choices": [
      {
        "id": 28404,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Timolol</span></span></span></p>"
      },
      {
        "id": 28405,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil</span></span></span></p>"
      },
      {
        "id": 28406,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Brimonidine</span></span></span></p>"
      },
      {
        "id": 28407,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acetazolamide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs increases trabecular outflow?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q3770546",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306447,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Netarsudil </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil is used in the treatment of glaucoma, it is a Rho-kinase inhibitor that acts by increasing the trabecular outflow. The other drugs that act by increasing the trabecular outflow are the miotic drugs like Pilocarpine, Physostigmine and Ecothiophate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A.</strong> <strong>Timolol: I</strong>s a non-selective Beta blocker which is used in treatment of glaucoma. It acts by reducing the aqueous formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong> Brimonidine:</strong>&nbsp;Is a topical alpha-receptor agonist. It acts by increasing the uveoscleral outflow and reduces the aqueous formation</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Acetazolamide:</strong>&nbsp;Is a carbonic anhydrase inhibitor which reduces aqueous formation</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Netarsudil is effective in treating glaucoma by increasing trabecular outflow. This mechanism distinguishes it from other drugs like Timolol, Brimonidine, and Acetazolamide, which primarily reduce aqueous humor production or increase uveoscleral outflow.</span></span></span></p>",
    "correct_choice_id": 28405,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7110,
    "choices": [
      {
        "id": 28408,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aromatase</span></span></span></p>"
      },
      {
        "id": 28409,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">17-hydrolase</span></span></span></p>"
      },
      {
        "id": 28410,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5-alpha reductase</span></span></span></p>"
      },
      {
        "id": 28411,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phosphodiesterase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Finasteride is used to treat male-pattern baldness acts by inhibiting which of the following enzymes?</span></span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q6731250",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306448,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. 5-alpha reductase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5-&alpha; Reductase is the enzyme that helps in the conversion of Testosterone into its active form Dihydrotestosterone (DHT). This is implicated in the causation of Androgenetic Alopecia or the male-pattern baldness. Finasteride is the drug that works by inhibiting the 5-&alpha; Reductase enzyme within the hair follicle, thereby preventing the male pattern hair loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Aromatase:</strong> Aromatase is the enzyme which converts androgens into estrogens. This enzyme is inhibited by Aromatase inhibitors which are Letrozole, Anastrozole and Exemestane</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>17-hydrolase:</strong> 17-hydrolase is the enzyme which is involved in Steroid biosynthesis. It is present in Adrenals and Ovaries.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Phosphodiesterase:</strong> Phosphodiesterase metabolize cGMP and cAMP. It is inhibited by PDE inhibitors like Theophylline (non-specific), Milrinone (PDE-3) and Sildenafil (PDE-5) etc.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Finasteride treats male-pattern baldness by inhibiting the enzyme 5-alpha reductase, which prevents the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for hair follicle miniaturization in androgenetic alopecia. This targeted inhibition helps in slowing hair loss and promoting hair regrowth.</span></span></span></p>",
    "correct_choice_id": 28410,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7111,
    "choices": [
      {
        "id": 28412,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal antibody which acts against CD20</span></span></span></p>"
      },
      {
        "id": 28413,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal antibody which acts against CD50</span></span></span></p>"
      },
      {
        "id": 28414,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoclonal antibody which acts against CD20</span></span></span></p>"
      },
      {
        "id": 28415,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoclonal antibody which acts against CD50</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rituximab is a:</span></span></span></p>",
    "unique_key": "Q8319535",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306449,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Monoclonal antibody which acts against CD20</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The suffix Mab implicates that it is a monoclonal antibody. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rituximab is a monoclonal antibody against CD-20 which is expressed on the B-cells.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is used in the treatment of B-cell lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal antibody which acts against CD20</span></strong>: Polyclonal antibodies are produced by multiple clones of B-cells and therefore recognize multiple epitopes. Rituximab is not a polyclonal antibody; it is a monoclonal antibody.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal antibody which acts against CD50</span></strong>: This is incorrect because rituximab is not polyclonal and does not target CD50.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monoclonal antibody which acts against CD50</span></strong>: This is incorrect because rituximab targets CD20, not CD50.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rituximab is a monoclonal antibody that targets the CD20 antigen on B-cells, making it effective in treating B-cell lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. The specificity of rituximab for CD20 allows it to selectively destroy B-cells, providing therapeutic benefits in these conditions.</span></span></span></p>",
    "correct_choice_id": 28414,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7112,
    "choices": [
      {
        "id": 28416,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4</span></span></span></p>"
      },
      {
        "id": 28417,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3</span></span></span></p>"
      },
      {
        "id": 28418,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2</span></span></span></p>"
      },
      {
        "id": 28419,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">New drug application is filed after which phase of clinical trials?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q7768801",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306450,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 3&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is after the phase 3 of clinical trials that the drug is finally released in the market after being approved by the CDSCO/FDA. Therefore, a New drug application is filed after phase 3 of clinical trials.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The phases of clinical trials are as follows: -</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Done in healthy individuals to assess the maximum tolerable dose, safety and pharmacokinetics of the drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Done in a small number of patients to find out whether the drug actually works or not, in other words to know about the treatment efficacy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Done in a large number of patients to compare the new treatment with the current standard of care. It is introduced into the market after this phase.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phase 4 </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- Post marketing surveillance to detect the rare or long-term adverse effects, can even result in the treatment being withdrawn from the market.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A New Drug Application (NDA) is filed after the successful completion of Phase 3 clinical trials, where the drug&#39;s effectiveness and safety are confirmed in a larger patient population. This phase is critical for regulatory approval and subsequent market release of the drug.</span></span></span></p>",
    "correct_choice_id": 28417,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24715,
    "choices": [
      {
        "id": 98821,
        "text": "<p><span style=\"font-size:12.0pt;\">Voglibose</span></p>"
      },
      {
        "id": 98822,
        "text": "<p><span style=\"font-size:12.0pt;\">Alogliptin</span></p>"
      },
      {
        "id": 98823,
        "text": "<p><span style=\"font-size:12.0pt;\">Pramlintide</span></p>"
      },
      {
        "id": 98824,
        "text": "<p><span style=\"font-size:12.0pt;\">Liraglutide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old female with diabetes mellitus has experienced a decrease in her HbA1c levels from 7.6 to 6.7 after starting a new oral medication. Laboratory tests show that she has high levels of GIP and GLP-1 and low levels of glucagon. Which of the following oral drugs was most likely administered to this patient?&nbsp;</span>(INICET MAY 2023)</p>",
    "unique_key": "Q2702561",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306451,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Alogliptin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alogliptin is a DPP-4 inhibitor, an oral class of drugs used in the treatment of diabetes. DPP-4 inhibitors work by preventing the breakdown of GLP-1, thereby increasing the levels of GLP-1 in the body, which in turn enhances insulin secretion, reduces glucagon secretion, and slows gastric emptying.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Voglibose</strong>: Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestines. It does not directly affect the levels of incretin hormones like GLP-1 and GIP, nor does it significantly influence glucagon levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pramlintide</strong>: Pramlintide is an amylin analogue that is used to help control blood sugar levels. It is typically administered by injection and does not significantly increase GLP-1 or GIP levels. It works by slowing gastric emptying and suppressing glucagon secretion, but it does not match the profile described in the question as closely as alogliptin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Liraglutide</strong>: Liraglutide is a GLP-1 agonist, which would indeed lead to increased GLP-1 levels and decreased glucagon levels. However, liraglutide is administered by injection and not orally. This makes it less likely to be the medication described in the scenario, which specifies an oral drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alogliptin, a DPP-4 inhibitor, is the most likely drug responsible for the increase in GLP-1 and GIP levels and the decrease in glucagon levels in this patient. It effectively lowers HbA1c levels and is administered orally, fitting the description provided.</span></p>",
    "correct_choice_id": 98822,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24716,
    "choices": [
      {
        "id": 98825,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone</span></span></span></p>"
      },
      {
        "id": 98826,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venlafaxine</span></span></span></p>"
      },
      {
        "id": 98827,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bupropion</span></span></span></p>"
      },
      {
        "id": 98828,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mirtazapine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male patient is being treated for a mood disorder. After starting a new medication, he experiences priapism, a prolonged, painful erection. The healthcare provider is considering changing the medication. Which drug is most likely responsible for causing priapism in this patient?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q9546469",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306452,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Trazodone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an atypical antidepressant that is often used off-label for insomnia. It is known to cause priapism as a rare but serious side effect. Given that the patient has a mood disorder and experienced priapism, trazodone is the most likely culprit.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Venlafaxine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat depression and anxiety disorders. While sexual dysfunction is a potential side effect, it is not commonly associated with priapism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Bupropion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an atypical antidepressant used for depression and smoking cessation. It is not commonly associated with priapism as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Mirtazapine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is another atypical antidepressant used for depression. It also has a low likelihood of causing priapism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trazodone is the most likely antidepressant to cause priapism among the listed options due to its known side effect profile. This serious condition necessitates careful monitoring and potentially switching medications to prevent recurrence.</span></span></span></p>",
    "correct_choice_id": 98825,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24717,
    "choices": [
      {
        "id": 98829,
        "text": "<p><span style=\"font-size:12.0pt;\">The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</span></p>"
      },
      {
        "id": 98830,
        "text": "<p><span style=\"font-size:12.0pt;\">The trial focused solely on the use of pembrolizumab for treating NSCLC.</span></p>"
      },
      {
        "id": 98831,
        "text": "<p><span style=\"font-size:12.0pt;\">The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC.</span></p>"
      },
      {
        "id": 98832,
        "text": "<p><span style=\"font-size:12.0pt;\">The trial looked at nivolumab as a treatment option for NSCLC.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An oncologist is discussing with a colleague about the latest evidence-based approaches to treating non-small cell lung cancer (NSCLC). The KEYNOTE-189 trial comes up in their conversation. Which of the following accurately describes the focus of the KEYNOTE-189 trial? (</span>INICET May 2023)</p>",
    "unique_key": "Q6873833",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306453,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The KEYNOTE trials are a series of clinical studies investigating the use of pembrolizumab, an immune checkpoint inhibitor, in various types of cancer. Pembrolizumab targets the PD-1 receptor, thereby enabling the immune system to better recognize and attack cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. The trial focused solely on the use of pembrolizumab for treating NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial investigated pembrolizumab in combination with chemotherapy, not as a monotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial did not involve nivolumab; it focused on pembrolizumab in combination with chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. The trial looked at nivolumab as a treatment option for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial was centered on pembrolizumab, not nivolumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110349.png\" alt=\"\" width=\"1000\" height=\"639\"></span></p>",
    "correct_choice_id": 98829,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24718,
    "choices": [
      {
        "id": 98833,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MDR1</span></span></span></p>"
      },
      {
        "id": 98834,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></span></span></p>"
      },
      {
        "id": 98835,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2</span></span></span></p>"
      },
      {
        "id": 98836,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient undergoing renal transplant management was started on cyclosporine as part of the immunosuppressive regimen. Within a few weeks, the patient begins to show elevated liver enzymes and bilirubin levels. The treating physician suspects drug-induced cholestasis and considers the involvement of a specific cellular transporter. Which cellular transporter is most likely responsible for cyclosporine-induced cholestasis in this patient</span></span></span></p>",
    "unique_key": "Q1336214",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306454,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. MRP2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2, also known as Multi-Drug Resistance-associated Protein 2 or ABCC2, is a membrane-bound transporter protein that belongs to the ATP-binding cassette (ABC) family of transporters. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This protein is primarily expressed in the liver, particularly in the canalicular membrane of hepatocytes, as well as in the kidneys, intestines, and other tissues.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 functions as an efflux pump, actively transporting a variety of substances out of cells including bile salts, bilirubin, glucuronides, and various drugs and their metabolites.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRP2 plays a critical role in the efflux of bile salts and bilirubin into the bile canaliculus. Mutations or inhibition of MRP2 (by drugs like cyclosporine) can lead to cholestasis, a condition where bile cannot flow from the liver to the duodenum.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dubin-Johnson Syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a genetic disorder resulting from mutations in the MRP2 gene, leading to conjugated hyperbilirubinemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. MDR 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Multi-Drug Resistance Protein 1 (MDR 1 or P-glycoprotein) is more known for its role in drug resistance, not specifically for cyclosporine-induced cholestasis. While MDR-1 plays a role in drug metabolism and can be inhibited by cyclosporine, it is generally not implicated in the development of drug-induced cholestasis, which is more closely associated with MRP2 inhibition.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BRCA</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The Breast Cancer Susceptibility Gene (BRCA) is not related to drug metabolism or cholestasis. It is mainly involved in DNA repair and cancer susceptibility.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">OATP1B1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Organic Anion Transporting Polypeptide 1B1 (OATP1B1) is involved in drug uptake into the liver but is not the key player in cyclosporine-induced cholestasis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRP2 (Multi-Drug Resistance-associated Protein 2) is the cellular transporter most likely responsible for cyclosporine-induced cholestasis due to its role in the efflux of bile salts and bilirubin into the bile canaliculus.</span></span></span></p>",
    "correct_choice_id": 98835,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24719,
    "choices": [
      {
        "id": 98837,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zavegepant</span></span></span></p>"
      },
      {
        "id": 98838,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide</span></span></span></p>"
      },
      {
        "id": 98839,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sparsentan</span></span></span></p>"
      },
      {
        "id": 98840,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elacestrant</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is a new approved drug for Rett syndrome. (</span></span></span>INICET May 2023)</p>",
    "unique_key": "Q7148277",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306455,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Trofinetide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett syndrome is an X-linked genetic disorder mostly seen in females. <span style=\"background-color:white\"><span style=\"color:#202122\">Symptoms include impairments in language and coordination, and repetitive movements. It occurs due to mutation in MECP2 gene.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide is an analog of&nbsp;glypromate&nbsp;or glycine&ndash;proline&ndash;glutamate (GPE), a naturally occurring protein in the brain and the N-terminal tripeptide of insulin-like growth factor 1 (IGF-1). GPE exhibits neuroprotective properties: it protects neurons from glutamate-mediated excitotoxicity and oxidative stress. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide has similar neuroprotective properties and has longer half-life.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Zavegepant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a CGRP antagonist approved for the treatment of migraine, not for Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sparsentan</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a dual endothelin antagonist and angiotensin receptor antagonist approved for the treatment of IgA nephropathy, not Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Elacestrant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a selective estrogen receptor downregulator approved as an oral treatment for breast cancer, not Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trofinetide is a newly approved drug for Rett syndrome, exhibiting neuroprotective properties similar to those of glypromate (GPE), and is beneficial for treating the symptoms of this genetic disorder.</span></span></span></p>",
    "correct_choice_id": 98838,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24720,
    "choices": [
      {
        "id": 98841,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acarbose </span></span></span></p>"
      },
      {
        "id": 98842,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Canagliflozin </span></span></span></p>"
      },
      {
        "id": 98843,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Linagliptin </span></span></span></p>"
      },
      {
        "id": 98844,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liraglutide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An individual with type 2 diabetes mellitus was prescribed a medication that lowered their HbA1C levels from 7.6 to 6.7. Subsequently, the person began experiencing discomfort characterized by itching in the vulvovaginal region. What is the probable medication that was initiated for this individual?&nbsp;</span></span></span>(INICET May 2023)</p>",
    "unique_key": "Q3589247",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306456,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Canagliflozin </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient complaining of itching in genital region after consuming a drug to lower down HbA1C levels is likely pointing to urogenital infection, which is a side effect associated with Canagliflozin (SGLT2 inhibitor).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SGLT-2 INHIBITORS</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose is freely filtered by glomerulus but the clearance of glucose in urine is negligible.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Because the reabsorption takes place in proximal tubule by sodium glucose transporter (SGLT-2)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SGLT-2 inhibitors stop the reabsorption of glucose in PT resulting in glucosuria.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most common side effect of SGLT-2 Inhibitors is Urinary Tract infections (urosepsis) and genital Tract infections. (e.g., Fournier&rsquo;s gangrene)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If gliflozins are taken by type 1 diabetes patients, it controls blood sugar level and makes it normal and then if the patients stop taking insulin, it will result in Ketoacidosis (as type 1 diabetes is characterized by complete deficiency of insulin)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SLGT-2 inhibitors provide cardiovascular benefits. These are approved for treatment of CHF.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs are. </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Canagliflozin </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapagliflozin </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Empagliflozin </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ertugliflozin </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Acarbose</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an alpha-glucosidase inhibitor that primarily acts in the intestine to slow down the breakdown of complex carbohydrates. It is not usually associated with vulvovaginal itching.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Linagliptin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A DPP-4 inhibitor, Linagliptin is not typically associated with vulvovaginal itching or infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Liraglutide</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This GLP-1 agonist is more commonly associated with gastrointestinal side effects rather than vulvovaginal itching.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Canagliflozin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is an SGLT2 inhibitor that lowers blood sugar by causing more glucose to be excreted in the urine. It is known for causing genitourinary infections, including vulvovaginal candidiasis, which can result in symptoms like itching and discomfort.</span></span></span></p>",
    "correct_choice_id": 98842,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24721,
    "choices": [
      {
        "id": 98845,
        "text": "<p><span style=\"font-size:12.0pt;\">Pethidine</span></p>"
      },
      {
        "id": 98846,
        "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
      },
      {
        "id": 98847,
        "text": "<p><span style=\"font-size:12.0pt;\">Naloxone</span></p>"
      },
      {
        "id": 98848,
        "text": "<p><span style=\"font-size:12.0pt;\">Buprenorphine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Following a hysterectomy, the patient received morphine for pain management both during the post-operative period and while in the ward. The current symptoms include respiratory depression and constricted (pinpoint) pupils. What would be the recommended medication for this patient?&nbsp;(</span><span style=\"font-size:11.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q2808198",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306457,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Naloxone</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given clinical scenario is suggestive of opioid poisoning due to morphine, for which IV Naloxone can be administered.</span></li><li><span style=\"font-size:12.0pt;\">In Morphine poisoning, the patient usually present in comatose state with low BP and heart rate as \u03bc-receptor causes depression of brain including cardiovascular center.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>SYMPTOMS OF OPIOID POISONING</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Coma, respiratory depression, pinpoint pupils</span></li><li><span style=\"font-size:12.0pt;\">Hypotension, bradycardia</span></li><li><span style=\"font-size:12.0pt;\">Bradypnea</span></li><li><span style=\"font-size:12.0pt;\">Hypothermia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>ANTAGONISTS</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Naloxone - Short acting, given iv</span></li><li><span style=\"font-size:12.0pt;\">Naltrexone - Long acting, given Orally</span></li><li><span style=\"font-size:12.0pt;\">DOC for acute opioid poisoning \u2192 Naloxone</span></li><li><span style=\"font-size:12.0pt;\">DOC for maintenance in opioid poisoning \u2192 Naltrexone</span><ul><li><span style=\"font-size:12.0pt;\">Naloxone is added to oral opioids to reduce addictive potential.</span></li><li><span style=\"font-size:12.0pt;\">Naltrexone is used to decrease craving in alcoholics.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> Pethidine/Meperidine is a \u03bc receptor agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> Atropine is an anticholinergic drug. Used in cases of organophosphate poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> Buprenorphine is a partial \u03bc receptor agonist and an antagonist at delta and kappa receptor. It has ceiling Effect on respiratory depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Naloxone is the drug of choice for treating acute opioid overdose, characterized by symptoms such as respiratory depression, pinpoint pupils, and coma. It acts rapidly to reverse the effects of opioids by competitively inhibiting their action at opioid receptors.</span></p>",
    "correct_choice_id": 98847,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29279,
    "choices": [
      {
        "id": 117022,
        "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
      },
      {
        "id": 117023,
        "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
      },
      {
        "id": 117024,
        "text": "<p><span style=\"font-size:12.0pt;\">Adrenaline</span></p>"
      },
      {
        "id": 117025,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-snake venom</span></p>"
      }
    ],
    "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12.0pt;\">A young boy recently visited a temple with his grandmother. Upon returning, he has been crying inconsolably, presenting with cold extremities and a blood pressure of 170/100 mm Hg. What is the most appropriate course of treatment for his condition?&nbsp;</span>(INICET MAY 2023)</p>",
    "unique_key": "Q1887978",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306458,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Prazosin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are suggestive of scorpion sting, characterized by symptoms of vasoconstriction like hypertension and cold extremities. Prazosin, an alpha-1 blocker is drug of choice for treatment of scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prednisolone</strong>: Prednisolone is a corticosteroid that reduces inflammation and suppresses the immune response. However, it is not typically used to manage scorpion stings, as it does not address the acute hypertensive crisis and autonomic storm caused by the sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Adrenaline</strong>: Adrenaline (epinephrine) is a catecholamine that increases heart rate and blood pressure. It would likely exacerbate the hypertension and vasoconstriction already present in the patient, making it an inappropriate treatment choice for scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Anti-snake venom</strong>: Anti-snake venom is used to neutralize the effects of snake bites. The symptoms described do not align with a snake bite but rather with a scorpion sting, making this treatment inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most appropriate treatment for a scorpion sting, which presents with severe pain, hypertension, and cold extremities, is prazosin. It effectively counters the effects of excessive catecholamine release by blocking alpha-1 adrenergic receptors, thereby reducing vasoconstriction and lowering blood pressure.</span></p>",
    "correct_choice_id": 117023,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29280,
    "choices": [
      {
        "id": 117026,
        "text": "<p><span style=\"font-size:12.0pt;\">It is approved for treatment of absent seizures</span></p>"
      },
      {
        "id": 117027,
        "text": "<p><span style=\"font-size:12.0pt;\">Fine tremors can be noted within therapeutic range</span></p>"
      },
      {
        "id": 117028,
        "text": "<p><span style=\"font-size:12.0pt;\">It does not cause teratogenicity</span></p>"
      },
      {
        "id": 117029,
        "text": "<p><span style=\"font-size:12.0pt;\">It is not absorbed orally</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements regarding lithium is correct?&nbsp;(INICET MAY 2023)</span></p>",
    "unique_key": "Q9655753",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306459,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Fine tremors can be noted within therapeutic range</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium is a commonly used medication for the treatment of bipolar disorder, but it can cause fine tremors within the therapeutic range. The tremors are generally mild and not a significant side effect for most patients, but in some cases, they can be bothersome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is approved for treatment of absent seizures</strong>: This is incorrect. Lithium is not used for the treatment of absent seizures. It is primarily used in the management of bipolar disorder and sometimes for treatment-resistant depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It does not cause teratogenicity</strong>: This is incorrect. Lithium can cause teratogenic effects, particularly if used during the first trimester of pregnancy. It is associated with an increased risk of cardiac anomalies, such as Ebstein's anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is not absorbed orally</strong>: This is incorrect. Lithium is well absorbed orally and reaches peak plasma concentrations within a few hours of ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium, a medication commonly used for bipolar disorder, can cause fine tremors within the therapeutic range. It is well absorbed orally and has teratogenic potential, making it important to use with caution in pregnant women.</span></p>",
    "correct_choice_id": 117027,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 29281,
    "choices": [
      {
        "id": 117030,
        "text": "<p><span style=\"font-size:12.0pt;\">Agranulocytosis</span></p>"
      },
      {
        "id": 117031,
        "text": "<p><span style=\"font-size:12.0pt;\">Akathisia</span></p>"
      },
      {
        "id": 117032,
        "text": "<p><span style=\"font-size:12.0pt;\">Respiratory depression</span></p>"
      },
      {
        "id": 117033,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperthermia</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is a rare but serious adverse effect of clozapine&nbsp;(INICET MAY 2023)</span></p>",
    "unique_key": "Q2137915",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306460,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Agranulocytosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Agranulocytosis&nbsp;</strong>is a rare but serious adverse effect of clozapine. Agranulocytosis is a condition characterized by a dangerously low level of neutrophils (a type of white blood cell) in the blood. Neutrophils are crucial for fighting infection, so their reduction significantly increases the risk of serious infections. Patients on clozapine are closely monitored with regular blood tests to detect this condition early.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Akathisia:</strong> This is a condition characterized by a feeling of inner restlessness and an inability to stay still. It is a common side effect of typical antipsychotics but it is unlikely to be seen with clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory depression:</strong> While antipsychotics can have sedating effects, respiratory depression is not commonly associated with clozapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperthermia:</strong> This is not typically associated with clozapine. Hyperthermia can occur with neuroleptic malignant syndrome (NMS), a rare but serious side effect of typical antipsychotics in general. It is not associated with the use of clozapine.</span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Agranulocytosis is a rare but serious adverse effect of clozapine, requiring regular monitoring of white blood cell counts to ensure early detection and prevention of serious infections.</span></p>",
    "correct_choice_id": 117030,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44805,
    "choices": [
      {
        "id": 178867,
        "text": "<p><span style=\"font-size:12.0pt;\">Aztreonam</span></p>"
      },
      {
        "id": 178868,
        "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
      },
      {
        "id": 178869,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
      },
      {
        "id": 178870,
        "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 45-year-old patient with a known allergy to penicillin presents with a enterococcal endocarditis. The physician needs to prescribe an antibiotic but wants to ensure it is safe for a patient with a penicillin allergy. The patient has had previous allergic reactions to penicillin, including rash and swelling. Which of the following drugs can be used safely in a patient allergic to penicillin?</span></p>",
    "unique_key": "Q2506207",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306461,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Vancomycin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical scenario involves a 45-year-old patient with enterococcal endocarditis and a known allergy to penicillin, presenting with previous allergic reactions including rash and swelling.&nbsp;</span></li><li><span style=\"font-size:12pt;\">The physician needs to choose an antibiotic that is safe for a patient with a penicillin allergy as well as effective for enterococcal endocarditis. Let's review the options:</span></li><li><span style=\"font-size:12pt;\">Vancomycin is a glycopeptide antibiotic that is not related to penicillin.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is safe for patients with penicillin allergies and is commonly used to treat gram-positive infections, including those caused by enterococci.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aztreonam: </strong>Aztreonam is a monobactam antibiotic that is generally considered safe for patients with penicillin allergies because it does not share the beta-lactam ring structure of penicillins, which is typically responsible for allergic reactions. However, aztreonam is effective only against gram negative bacteria and is not suitable for enterococcal infections which is a gram positive bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ceftriaxone: </strong>Ceftriaxone is a third-generation cephalosporin. Although cephalosporins have a beta-lactam ring similar to penicillins, the rate of cross-reactivity is relatively low, especially with third-generation cephalosporins. However, caution is advised in patients with a history of severe penicillin allergy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Piperacillin: </strong>Piperacillin is a penicillin derivative and should be avoided in patients with penicillin allergies due to the high risk of cross-reactivity and potential for severe allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Conclusion</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The safest options for a patient with a penicillin allergy are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aztreonam (Option a)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vancomycin (Option b)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the specific need to avoid penicillin and its derivatives and to treat gram positive (enterococcal) infections, Vancomycin is a safe and effective choice for treating enterococcal endocarditis in this patient. Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">b. Vancomycin</span></p>",
    "correct_choice_id": 178868,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44816,
    "choices": [
      {
        "id": 178911,
        "text": "<p><span style=\"font-size:12.0pt;\">Osmotic diuretics- Collecting duct</span></p>"
      },
      {
        "id": 178912,
        "text": "<p><span style=\"font-size:12.0pt;\">Carbonic anhydrase inhibitors-Proximal tubule</span></p>"
      },
      {
        "id": 178913,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazides-Loop of Henle</span></p>"
      },
      {
        "id": 178914,
        "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone antagonists- early Distal tubules</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following diuretic is correctly matched with its site of action (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20132839.jpg\" width=\"783\" height=\"265\"></p>",
    "unique_key": "Q6819023",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306462,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Carbonic anhydrase inhibitors - Proximal tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Carbonic anhydrase inhibitors</strong> - These act in the <strong>proximal tubule</strong>. Acetazolamide is a commonly used carbonic anhydrase inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Osmotic diuretics- Collecting duct:</strong></span><span style=\"font-size:12pt;\"><strong> </strong>These work primarily in the <strong>proximal tubule</strong> and the <strong>descending limb of the loop of Henle</strong>, not the collecting duct. Mannitol is a common example.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Thiazides-Loop of Henle:</strong></span><span style=\"font-size:12pt;\"><strong> </strong>These primarily act on the <strong>distal convoluted tubule</strong>. Hydrochlorothiazide is a typical example.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Aldosterone antagonists- early&nbsp;Distal tubules:</strong></span><span style=\"font-size:12pt;\"> These work in the <strong>collecting ducts and late distal tubules</strong>. Spironolactone is a well-known aldosterone antagonist.</span></p>",
    "correct_choice_id": 178912,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44819,
    "choices": [
      {
        "id": 178923,
        "text": "<p><span style=\"font-size:12pt;\">Conjugated estrogen</span></p>"
      },
      {
        "id": 178924,
        "text": "<p><span style=\"font-size:12pt;\">Estrone</span></p>"
      },
      {
        "id": 178925,
        "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
      },
      {
        "id": 178926,
        "text": "<p><span style=\"font-size:12pt;\">Estriol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Most potent natural estrogen is (INICET MAY 2024)</span></p>",
    "unique_key": "Q6840690",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306463,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol (E2) is the most potent natural estrogen. It is the primary estrogen produced by the ovaries during the reproductive years and plays a crucial role in regulating the menstrual cycle and reproductive system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Conjugated estrogen</strong>: Conjugated estrogen like Ethinyl estradiol is a synthetic estrogen commonly used in oral contraceptives. It is not a natural estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Estrone</strong>: Estrone (E1) is one of the three naturally occurring estrogens. It is less potent than estradiol. Estrone is primarily produced in adipose tissue and is the predominant estrogen after menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Estriol</strong>: Estriol (E3) is the weakest of the three natural estrogens. It is primarily produced during pregnancy by the placenta. Estriol has much lower estrogenic activity compared to estradiol and estrone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, estradiol is the most potent natural estrogen and plays a significant role in the female reproductive system during the reproductive years.</span></p>",
    "correct_choice_id": 178925,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44823,
    "choices": [
      {
        "id": 178939,
        "text": "<p><span style=\"font-size:12pt;\">Syrup Dextromethorphan with bromhexine</span></p>"
      },
      {
        "id": 178940,
        "text": "<p><span style=\"font-size:12pt;\">Syrup Codeine</span></p>"
      },
      {
        "id": 178941,
        "text": "<p><span style=\"font-size:12.0pt;\">Syrup dextromethorphan</span></p>"
      },
      {
        "id": 178942,
        "text": "<p><span style=\"font-size:12pt;\">Syrup bromhexine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 30-year-old patient presented with fever, cough and tenacious white sputum. Which of the following should be used for treatment? (INICET MAY 2024)</span></p>",
    "unique_key": "Q2531058",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306464,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Syrup bromhexine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Bromhexine is a mucolytic agent that helps to thin and loosen mucus, making it easier to expectorate. This is particularly useful for patients with a productive cough and tenacious sputum, as it facilitates the clearance of mucus from the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Syrup Dextromethorphan with bromhexine</strong>: Dextromethorphan is a cough suppressant, and bromhexine is a mucolytic. While bromhexine can help thin the mucus, dextromethorphan is not recommended for productive coughs as it suppresses the cough reflex, potentially leading to mucus retention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Syrup Codeine</strong>: Codeine is an opioid cough suppressant. Like dextromethorphan, it is not suitable for productive coughs as it suppresses the cough reflex, which can lead to mucus accumulation in the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Syrup Dextromethorphan</strong>: Dextromethorphan is a cough suppressant that is not appropriate for productive coughs, as it can prevent the clearing of mucus from the respiratory tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, syrup bromhexine is the most appropriate choice for treating a patient with fever, cough, and tenacious white sputum, as it helps to thin and loosen the mucus, making it easier to clear from the respiratory tract.</span></p>",
    "correct_choice_id": 178942,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44826,
    "choices": [
      {
        "id": 178951,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></span></p>"
      },
      {
        "id": 178952,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></span></p>"
      },
      {
        "id": 178953,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></p>"
      },
      {
        "id": 178954,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old patient presents with progressive dyspnoea at rest and on exertion (e.g., climbing stairs). The patient also has a history of heart failure. Laboratory tests show a fasting plasma glucose of 136 mg/dL, haemoglobin (Hb) of 13 g%, and HbA1c of 7.8%, indicating poorly controlled type 2 diabetes mellitus. The physician needs to select an appropriate antidiabetic medication considering the patient&#39;s symptoms and medical condition. Which is the preferred antidiabetic drug in this patient?</span></span></span>(INICET MAY 2024)</p>",
    "unique_key": "Q7453314",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306465,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin is an SGLT2 inhibitor that promotes glucose excretion through the urine. It has been shown to provide significant benefits in patients with type 2 diabetes and heart failure, including reducing the risk of hospitalization for heart failure and cardiovascular death. Given the patient&#39;s history of heart failure, dapagliflozin is a preferred choice due to its cardiovascular benefits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glimepiride</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride is a sulfonylurea that increases insulin secretion. It is associated with a risk of hypoglycemia and weight gain, which might not be ideal for this patient considering the need to manage cardiovascular risk factors and avoid potential hypoglycemic episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin is a first-line treatment for type 2 diabetes due to its efficacy and safety profile. However, in this case, given the patient&#39;s history of heart failure, dapagliflozin may provide additional cardiovascular benefits that make it a more suitable choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sitagliptin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin is a DPP-4 inhibitor that helps improve blood glucose control with a low risk of hypoglycemia and is weight neutral. While it is effective, it does not have the same cardiovascular benefits as dapagliflozin in patients with heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In summary, dapagliflozin is the preferred antidiabetic drug for this patient due to its proven benefits in reducing heart failure-related outcomes, making it particularly suitable for a patient with a history of heart failure and poorly controlled diabetes.</span></span></p>",
    "correct_choice_id": 178951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44827,
    "choices": [
      {
        "id": 178955,
        "text": "<p><span style=\"font-size:12pt;\">Chancroid</span></p>"
      },
      {
        "id": 178956,
        "text": "<p><span style=\"font-size:12pt;\">Donovanosis</span></p>"
      },
      {
        "id": 178957,
        "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
      },
      {
        "id": 178958,
        "text": "<p><span style=\"font-size:12pt;\">Gonorrhea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Drug resistance is most commonly seen with which of the following infections? (INICET MAY 2024)</span></p>",
    "unique_key": "Q7722657",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306466,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Gonorrhea</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Gonorrhea is caused by the bacterium Neisseria gonorrhoeae. It is notorious for developing resistance to multiple classes of antibiotics, including penicillins, tetracyclines, fluoroquinolones, and most recently, some strains have shown reduced susceptibility to cephalosporins and azithromycin. Drug-resistant gonorrhea is a significant public health challenge, and the CDC recommends dual therapy with ceftriaxone and azithromycin to address this issue.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Chancroid</strong>: Chancroid is caused by the bacterium Haemophilus ducreyi. While there have been cases of antibiotic resistance, it is not as prevalent or significant as in gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Donovanosis</strong>: Donovanosis (granuloma inguinale) is caused by Klebsiella granulomatis. It is relatively rare, and drug resistance has not been a major issue in its treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C.</strong>&nbsp;<strong>Syphilis</strong>: Syphilis is caused by the bacterium Treponema pallidum. While there are concerns about resistance to some antibiotics, such as macrolides, penicillin remains highly effective, and resistance is not as significant a problem as in gonorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, gonorrhea is the infection most commonly associated with drug resistance, making it a critical concern in the treatment of STIs.</span></p>",
    "correct_choice_id": 178958,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44828,
    "choices": [
      {
        "id": 178959,
        "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
      },
      {
        "id": 178960,
        "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
      },
      {
        "id": 178961,
        "text": "<p><span style=\"font-size:12pt;\">Nitrous oxide</span></p>"
      },
      {
        "id": 178962,
        "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Inhalational anaesthetic agent of choice in children is</span>(INICET MAY 2024)</p>",
    "unique_key": "Q4227132",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306467,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sevoflurane</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sevoflurane is the inhalational anesthetic agent of choice in children. It has a rapid onset and offset, a pleasant smell, and causes minimal airway irritation, making it ideal for inhalational induction in pediatric patients. It also has a relatively low blood-gas partition coefficient, leading to quick recovery times.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Desflurane</strong>: Desflurane is another potent inhalational anesthetic with a very low blood-gas partition coefficient, resulting in rapid induction and emergence from anesthesia. However, it can cause airway irritation and coughing, making it less suitable for children, particularly for inhalational induction.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Nitrous oxide</strong>: Nitrous oxide is commonly used as an adjunct to other anesthetic agents due to its analgesic properties and rapid onset. However, it is not used as the sole agent for induction of anesthesia because it is not potent enough to achieve surgical anesthesia on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Isoflurane</strong>: Isoflurane is a potent inhalational anesthetic but has a pungent odor and can cause airway irritation. It is less commonly used for inhalational induction in children due to these properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sevoflurane is preferred for pediatric anesthesia due to its favorable profile, including rapid onset and recovery, minimal airway irritation, and a pleasant smell, making it well-tolerated by children.</span></p>",
    "correct_choice_id": 178959,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44829,
    "choices": [
      {
        "id": 178963,
        "text": "<p><span style=\"font-size:12pt;\">Evolocumab</span></p>"
      },
      {
        "id": 178964,
        "text": "<p><span style=\"font-size:12pt;\">Ezetimibe</span></p>"
      },
      {
        "id": 178965,
        "text": "<p><span style=\"font-size:12pt;\">Evinacumab</span></p>"
      },
      {
        "id": 178966,
        "text": "<p><span style=\"font-size:12pt;\">Everolimus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following is a PCSK-9 inhibtior? (</span>INICET May 2024)</p>",
    "unique_key": "Q4341520",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306468,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Evolocumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK-9). By inhibiting PCSK-9, evolocumab increases the number of low-density lipoprotein (LDL) receptors available on the surface of liver cells, thereby reducing LDL cholesterol levels in the blood. It is used for the treatment of hypercholesterolemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ezetimibe</strong>:&nbsp;Ezetimibe is a cholesterol absorption inhibitor that works by reducing the absorption of cholesterol in the small intestine. It is used to lower LDL cholesterol levels but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Evinacumab</strong>:&nbsp;Evinacumab is a monoclonal antibody that inhibits angiopoietin-like protein 3 (ANGPTL3), which reduces levels of triglycerides, LDL cholesterol, and other lipids. It is used for treating homozygous familial hypercholesterolemia but is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Everolimus</strong>:&nbsp;Everolimus is an mTOR inhibitor used primarily as an immunosuppressant in transplant patients and in certain types of cancer. It is not related to cholesterol metabolism and is not a PCSK-9 inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, evolocumab is the correct answer as it is a PCSK-9 inhibitor used to lower LDL cholesterol levels.</span></p>",
    "correct_choice_id": 178963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44830,
    "choices": [
      {
        "id": 178967,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is un-competitive inhibitor</span></p>"
      },
      {
        "id": 178968,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is non-competitive inhibitor</span></p>"
      },
      {
        "id": 178969,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is non-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      },
      {
        "id": 178970,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is un-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the drugs shown in graph A and graph B is correct. (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/22/screenshot-2024-05-22-155759.png\" alt=\"\" width=\"400\" height=\"160\"></p>",
    "unique_key": "Q9825503",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306469,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans&nbsp;B) Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To determine the correct answer, let's analyze the Lineweaver-Burk plots and the types of enzyme inhibition they represent:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For non-competitive inhibitors, the lines intersect at the x-axis. This type of inhibitor decreases VmaxVmax\u200b without affecting KmKm\u200b.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Competitive Inhibition</strong>: On a Lineweaver-Burk plot, competitive inhibitors intersect with the no-inhibitor line at the y-axis. This is because competitive inhibitors increase the apparent KmKm\u200b (Michaelis constant) without affecting VmaxVmax\u200b (maximum velocity).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uncompetitive Inhibition</strong>: Uncompetitive inhibitors result in parallel lines on the Lineweaver-Burk plot. They decrease both VmaxVmax\u200b and KmKm\u200b proportionally.</span>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Given the descriptions of the graphs:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Graph A</strong>: The lines meet at the y-axis, indicating competitive inhibition.</span></li><li><span style=\"font-size:12pt;\"><strong>Graph B</strong>: The lines start from the same point on the x-axis, indicating non-competitive inhibition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B. Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p>",
    "correct_choice_id": 178968,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44831,
    "choices": [
      {
        "id": 178971,
        "text": "<p><span style=\"font-size:12pt;\">Dravet Syndrome</span></p>"
      },
      {
        "id": 178972,
        "text": "<p><span style=\"font-size:12pt;\">Tuberous sclerosis</span></p>"
      },
      {
        "id": 178973,
        "text": "<p><span style=\"font-size:12pt;\">Rett syndrome</span></p>"
      },
      {
        "id": 178974,
        "text": "<p><span style=\"font-size:12pt;\">Lennox Gastaut syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Cannabinoids are not approved for treatment of (</span>INICET May 2024)</p>",
    "unique_key": "Q3673868",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306470,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Rett syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cannabinoids, including cannabidiol (CBD), are not currently approved for the treatment of Rett syndrome.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Rett syndrome is a rare genetic neurological disorder, and while there is ongoing research into potential treatments, cannabinoids are not among the approved therapies for this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Dravet Syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Dravet Syndrome, a severe form of epilepsy. It is used to reduce the frequency of seizures in patients with this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Tuberous sclerosis</strong>: Cannabidiol (CBD) is also approved for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). It has been shown to reduce seizure frequency in patients with TSC.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Lennox Gastaut syndrome</strong>: Cannabidiol (CBD) is approved for the treatment of Lennox-Gastaut Syndrome, another severe form of epilepsy. It is used to help reduce the frequency of seizures in patients with this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, cannabinoids, specifically cannabidiol (CBD), are not approved for the treatment of Rett syndrome, whereas they are approved for use in Dravet Syndrome, Tuberous Sclerosis, and Lennox-Gastaut Syndrome.</span></p>",
    "correct_choice_id": 178973,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44833,
    "choices": [
      {
        "id": 178979,
        "text": "<p><span style=\"font-size:12pt;\">It should not be given with pyrazinamide</span></p>"
      },
      {
        "id": 178980,
        "text": "<p><span style=\"font-size:12pt;\">It should be taken empty stomach</span></p>"
      },
      {
        "id": 178981,
        "text": "<p><span style=\"font-size:12pt;\">It is given as a loading dose</span></p>"
      },
      {
        "id": 178982,
        "text": "<p><span style=\"font-size:12pt;\">It requires therapeutic drug monitoring</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 50-year-old male patient with a history of chronic pulmonary aspergillosis is being treated with voriconazole. He has been on the medication for two weeks and comes to the clinic for a follow-up. During the visit, he asks about the specific guidelines and considerations for taking voriconazole to ensure its effectiveness and safety. Which of the following statements is true about voriconazole? (</span>INICET May 2024)</p>",
    "unique_key": "Q9467334",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306471,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) It is given as a loading dose</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Voriconazole requires a loading dose to rapidly achieve therapeutic levels in the body. This is a crucial aspect of its administration, especially in acute settings where rapid antifungal activity is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>It should not be given with pyrazinamide</strong>: There is no significant interaction between voriconazole and pyrazinamide. Voriconazole does interact with many other medications due to its effect on cytochrome P450 enzymes, but pyrazinamide is not one of the primary concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It should be taken empty stomach</strong>: Voriconazole can be taken either with or without food, but it is generally recommended to take it one hour before or one hour after a meal to ensure optimal absorption. While this is important, it is not the most critical consideration compared to therapeutic drug monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>It requires therapeutic drug monitoring</strong>: While therapeutic drug monitoring can be important for voriconazole, especially in certain patient populations, it is not as universally mandated or emphasized as the initial loading dose regimen in standard treatment protocols.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the statement that voriconazole \"is given as a loading dose\" is the most universally applicable and critical aspect of its administration, especially for ensuring rapid therapeutic levels in treating fungal infections.</span></p>",
    "correct_choice_id": 178981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44836,
    "choices": [
      {
        "id": 178991,
        "text": "<p><span style=\"font-size:12pt;\">Cetuximab</span></p>"
      },
      {
        "id": 178992,
        "text": "<p><span style=\"font-size:12pt;\">Necitumumab</span></p>"
      },
      {
        "id": 178993,
        "text": "<p><span style=\"font-size:12pt;\">Pertuzumab</span></p>"
      },
      {
        "id": 178994,
        "text": "<p><span style=\"font-size:12pt;\">Panitumumab</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">All of the following drugs act as HER-1 inhibitors except (</span>INICET May 2024)</p>",
    "unique_key": "Q8535318",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306472,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Pertuzumab</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Pertuzumab is a monoclonal antibody that targets HER-2 (Human Epidermal Growth Factor Receptor 2), not HER-1.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is used primarily in the treatment of HER-2 positive breast cancer.</span></li><li><span style=\"font-size:12pt;\">HER-1 (Human Epidermal Growth Factor Receptor 1) is also known as EGFR (Epidermal Growth Factor Receptor).&nbsp;</span></li><li><span style=\"font-size:12pt;\">Several monoclonal antibodies target EGFR, while others target different members of the HER family, such as HER-2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Cetuximab</strong>: Cetuximab is an EGFR (HER-1) inhibitor used primarily in the treatment of certain types of colorectal cancer and head and neck cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Necitumumab</strong>: Necitumumab is also an EGFR (HER-1) inhibitor, used in the treatment of metastatic squamous non-small cell lung cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Panitumumab</strong>: Panitumumab is an EGFR (HER-1) inhibitor, used in the treatment of metastatic colorectal cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given this information, the drug that does not act as a HER-1 inhibitor is:&nbsp;</span><br><span style=\"font-size:12pt;\"><strong>c. Pertuzumab</strong></span></p>",
    "correct_choice_id": 178993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44841,
    "choices": [
      {
        "id": 179011,
        "text": "<p><span style=\"font-size:12pt;\">Sugammadex</span></p>"
      },
      {
        "id": 179012,
        "text": "<p><span style=\"font-size:12pt;\">Neostigmine</span></p>"
      },
      {
        "id": 179013,
        "text": "<p><span style=\"font-size:12pt;\">Edrophonium</span></p>"
      },
      {
        "id": 179014,
        "text": "<p><span style=\"font-size:12pt;\">Atropine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 60-year-old male patient underwent surgery under general anaesthesia. Rocuronium was used as a muscle relaxant during the procedure. After the surgery, the patient has not regained muscle function, indicating prolonged muscle paralysis. The medical team needs to reverse the effects of rocuronium quickly to ensure patient safety and recovery. Which of the following can result in the fastest reversal? (INICET MAY 2024)</span></p>",
    "unique_key": "Q2279563",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306473,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sugammadex</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Neostigmine</strong>: Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Edrophonium</strong>: Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Atropine</strong>: Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sugammadex is the most effective and fastest-acting agent for reversing the effects of rocuronium, making it the best choice in this clinical scenario.</span></p>",
    "correct_choice_id": 179011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44847,
    "choices": [
      {
        "id": 179035,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 12 mg 24 hourly 2 doses</span></span></span></p>"
      },
      {
        "id": 179036,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></span></span></p>"
      },
      {
        "id": 179037,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 12 hourly 2 doses</span></span></span></p>"
      },
      {
        "id": 179038,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone 12 mg 24 hourly 4 doses</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation: (</span></span></span>INICET May 2024)</p>",
    "unique_key": "Q4116255",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306474,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone 6 mg 12 hourly 4 doses</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For promoting fetal lung maturation in cases of threatened preterm labor, corticosteroids are administered to enhance the production of surfactant, which helps in reducing the risk of neonatal respiratory distress syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonly recommended regimens are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 12 mg intramuscularly every 24 hours for 2 doses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 6 mg intramuscularly every 12 hours for 4 doses.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given these recommendations, the correct options is:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Dexamethasone 6 mg 12 hourly 4 doses</span></span></strong></p>",
    "correct_choice_id": 179036,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44852,
    "choices": [
      {
        "id": 179055,
        "text": "<p><span style=\"font-size:12pt;\">1, 2 and 4</span></p>"
      },
      {
        "id": 179056,
        "text": "<p><span style=\"font-size:12pt;\">1, 3 and 4</span></p>"
      },
      {
        "id": 179057,
        "text": "<p><span style=\"font-size:12pt;\">1, 2 and 3</span></p>"
      },
      {
        "id": 179058,
        "text": "<p><span style=\"font-size:12pt;\">2, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following drug is/are used for cyanide poisoning?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Amyl nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium thiosulfate</span></li><li><span style=\"font-size:12pt;\">Glyceryl trinitrate</span></li></ol>",
    "unique_key": "Q8757926",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306475,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cyanide poisoning, the following treatments are commonly used:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1.</strong>&nbsp;<strong>Amyl nitrite</strong>: This is an inhalant that induces methemoglobinemia, which binds cyanide ions and forms cyanmethemoglobin, helping to detoxify cyanide.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">2&nbsp;<strong>Sodium nitrite</strong>: This intravenous agent also induces methemoglobinemia, which helps to bind and neutralize cyanide.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3.</strong>&nbsp;<strong>Sodium thiosulfate</strong>: This acts as a sulfur donor, converting cyanide to the less toxic thiocyanate, which is excreted by the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4.</strong>&nbsp;<strong>Glyceryl trinitrate</strong> (commonly known as nitroglycerin) is not typically used for cyanide poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Based on the options provided, the correct combination of drugs used for cyanide poisoning is:&nbsp;<strong>1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. 1, 2, and 3</strong></span></p>",
    "correct_choice_id": 179057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44860,
    "choices": [
      {
        "id": 179087,
        "text": "<p><span style=\"font-size:16px;\">1, 2 and 3</span></p>"
      },
      {
        "id": 179088,
        "text": "<p><span style=\"font-size:16px;\">1 and 3</span></p>"
      },
      {
        "id": 179089,
        "text": "<p><span style=\"font-size:16px;\">2, 3 and 4</span></p>"
      },
      {
        "id": 179090,
        "text": "<p><span style=\"font-size:16px;\">1, 2, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is a suicide inhibitor?&nbsp; (INICET May 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Nor-ethindrone</span></li><li><span style=\"font-size:16px;\">Ritonavir</span></li><li><span style=\"font-size:16px;\">Spironolactone</span></li><li><span style=\"font-size:16px;\">Benzbromarone</span></li></ol>",
    "unique_key": "Q2983402",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306476,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A&nbsp;suicide inhibitor&nbsp;(also known as a mechanism-based inhibitor) is a type of enzyme inhibitor that binds to an enzyme and undergoes a catalytic reaction, leading to the formation of an irreversible complex. During this reaction, the inhibitor is converted into a reactive form by the enzyme itself, which then covalently binds to the enzyme, permanently inactivating it.&nbsp;In essence, the enzyme \u201ccommits suicide\u201d by converting the inhibitor into a form that irreversibly binds to it, thereby blocking the enzyme's activity permanently.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Among the given options, nor-ethindrone, ritonavir and spironolactone are suicide inhibitors whereas benzbromarone is not.&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Nor-ethindrone</strong>: Nor-ethindrone is a synthetic progestin that is commonly used in hormonal contraceptives. It is also classified as a&nbsp;<strong>suicide inhibitor</strong>&nbsp;due to its irreversible binding to its target enzyme, leading to permanent inhibition of enzyme activity.</span></li><li><span style=\"font-size:16px;\"><strong>Ritonavir</strong>: Ritonavir is an HIV protease inhibitor that acts as a&nbsp;<strong>suicide inhibitor</strong>. It binds irreversibly to the HIV protease enzyme, permanently inactivating it.</span></li><li><span style=\"font-size:16px;\"><strong>Spironolactone</strong>: Spironolactone is a potassium-sparing diuretic and aldosterone antagonist. It is also categorized as a&nbsp;<strong>suicide inhibitor</strong>&nbsp;because it irreversibly inhibits the 17\u03b1-hydroxylase enzyme involved in steroid synthesis.</span></li><li><span style=\"font-size:16px;\"><strong>Benzbromarone:&nbsp;</strong>Benzbromarone is a uricosuric drug used to treat gout by increasing the renal excretion of uric acid. However, it is not classified as a suicide inhibitor. While it has therapeutic uses, it does not act by irreversibly inactivating enzymes like suicide inhibitors do.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Suicide inhibitors, also known as mechanism-based inhibitors, irreversibly bind to and permanently inactivate their target enzymes. This type of inhibition is significant because the enzyme activity cannot be restored unless new enzymes are synthesized by the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Mnemonic to Remember Important Suicide Inhibitors:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>\u201cEvery Nurse Sees The Clot Results Promptly\u201d</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>E</strong>: Ethinyl estradiol</span></li><li><span style=\"font-size:16px;\"><strong>N</strong>: Norethindrone</span></li><li><span style=\"font-size:16px;\"><strong>S</strong>: Spironolactone</span></li><li><span style=\"font-size:16px;\"><strong>T</strong>: Ticlopidine</span></li><li><span style=\"font-size:16px;\"><strong>C</strong>: Clopidogrel</span></li><li><span style=\"font-size:16px;\"><strong>R</strong>: Ritonavir</span></li><li><span style=\"font-size:16px;\"><strong>P</strong>: Propylthiouracil</span></li></ul>",
    "correct_choice_id": 179087,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44862,
    "choices": [
      {
        "id": 179095,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin</span></span></span></p>"
      },
      {
        "id": 179096,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></span></span></p>"
      },
      {
        "id": 179097,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fondaparinux</span></span></span></p>"
      },
      {
        "id": 179098,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anticoagulant requires coagulation profile monitoring? (</span></span></span>INICET May 2024)</p>",
    "unique_key": "Q9926497",
    "question_audio": null,
    "question_video": null,
    "map_id": 33306477,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lepirudin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct thrombin inhibitor that typically requires regular monitoring of anticoagulant effect via activated partial thromboplastin time (aPTT).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(a low molecular weight heparin), <strong>Fondaparinux</strong> (a synthetic pentasaccharide), and <strong>Dabigatran</strong> (a direct thrombin inhibitor) generally do not require regular monitoring in most patients, although there may be specific clinical situations where monitoring is needed.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 179096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Pharmacology-3)';
        const quizFilename = 'late-night-pyq-inicet-pharmacology-3-d41b8526.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>